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Abstract 
Discovery of new antifungal chemo-therapeutics for humans is limited by the 
large degree of conservation among eukaryotic organisms. In recent years, the histone 
acetyl-transferase Rtt109 was identified as the sole enzyme responsible for an 
abundant and important histone modification, histone H3 lysine 56 (H3K56) 
acetylation. In the absence of Rtt109, the lack of acetylated H3K56 renders yeast cells 
extremely sensitive to genotoxic agents. Consequently, the ability to sustain 
genotoxic stress from the host immune system is crucial for pathogens to perpetuate 
an infection. Because Rtt109 is conserved only within the fungal kingdom, I reasoned 
that Rtt109 could be a novel drug target.  
My dissertation first establishes that genome stability provided by Rtt109 and 
H3K56 acetylation is required for Candida albicans pathogenesis. I demonstrate that 
mice infected with rtt109-/- cells experience a significant reduction in organ pathology 
and mortality rate. I hypothesized that the avirulent phenotype of rtt109 -/- cells is due 
to their intrinsic hypersensitivity to the genotoxic effects of reactive oxygen species 
(ROS), which are utilized by phagocytic cells of the immune system to kill 
pathogens. Indeed, C. albicans rtt109 -/- cells are more efficiently killed by 
macrophages in vitro than are wild-type cells. However, inhibition of ROS generation 
in macrophages renders rtt109 -/- and wild-type yeast cells equally resilient to killing. 
These findings support the concept that ability to resist genotoxic stress conferred by 
Rtt109 and H3K56 acetylation is a virulence factor for fungal pathogens and establish 
Rtt109 as an opportune drug- target for novel antifungal therapeutics. 
vi 
Second, I report the discovery of a specific chemical inhibitor of Rtt109 
catalysis as the initial step in the development of a novel antifungal agent. We 
established a collaboration with the Broad Institute (Cambridge, MA) to perform a 
high-throughput screen of 300,000 compounds. From these, I identified a single 
chemical, termed KB7, which specifically inhibits Rtt109 catalysis, with no effect on 
other HAT enzymes tested. KB7 has an IC50 value of approximately 60 nM and 
displays noncompetitive inhibition regarding both acetyl-coenzyme A and histone 
substrates. With the genotoxic agent camptothecin, KB7 causes a synergistic decrease 
in C. albicans growth rate. However, this effect is only observed in an efflux-pump 
mutant, suggesting that this compound would be more effective if it were better 
retained intracellularly. Further studies through structure-activity relationship (SAR) 
modifications will be conducted on KB7 to improve its effective cellular 
concentration. 
vii 
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PREFACE 
Not included in this dissertation is the following publication: 
Lopes da Rosa, J., Holik, J., Green, E.M., Rando, O.J., and Kaufman, P.D. (2011) 
Overlapping Regulation of CenH3 Localization and Histone H3 Turnover by CAF-1 
and HIR Proteins in Saccharomyces cerevisiae. Genetics 187 (1) 9-19. 
CHAPTER 1 
Introduction 
 
Acknowledgement: The following introductory chapter contains excerpts (section 2 
and 3) from a published review article written by myself and Dr. Paul D. Kaufman: 
Lopes da Rosa, J. and Kaufman, P.D. (2012) Chromatin-mediated Candida albicans 
virulence. Biochim Biophys Acta, 1819 (3-4). 
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 1. General Background 
 Eukaryotic genomes are assembled into a nucleoprotein complex called 
chromatin. Organization of DNA into chromatin allows for the compaction of large 
genomes into relatively small nuclei. The nucleosome, the fundamental repeating unit 
of chromatin is a protein octamer of two histone H2A- H2B dimers flanking a histone 
(H3-H4)2 tetramer wrapped by 147 base pairs of DNA (Davey et al., 2002; Luger et 
al., 1997). Histones are generally inhibitory to biological processes because of their 
extensive contacts with the DNA. Several general molecular mechanisms are used to 
counter this inhibition and generate access to DNA in chromatin. First, nucleosomes 
are moved along the DNA fiber or are evicted by ATPase “remodeling” enzymes, 
thereby regulating DNA accessibility (reviewed in (Smith and Peterson, 2005)). 
Second, histones undergo a wide variety of covalent modifications to modulate 
nucleosome assembly, transcription, formation of silenced heterochromatin, and 
DNA repair (reviewed in (Allard et al., 2004; Kouzarides, 2007; Millar and 
Grunstein, 2006; Moore and Krebs, 2004)). Post-translation modifications (PTMs) on 
histones involve acetylation, methylation, phosphorylation, ubiquitylation and 
sumoylation. These modifications often provide binding sites for trans-acting proteins 
(reviewed in (Ruthenburg et al., 2007)). In the case of histone H4 lysine 16 
acetylation, the modification also directly alters the higher-order folding properties of 
chromatin (Shogren-Knaak et al., 2006). Together, increased DNA accessibility and 
protein recruitment facilitate chromatin function (reviewed in (Kouzarides, 2007; 
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Sinha and Peterson, 2009)). Chromatin also contributes directly to genome stability as 
the platform for kinetochore formation, the structures that attach to microtubules for 
chromosome segregation during mitosis (reviewed in (Cheeseman and Desai, 2008)).  
In recent years, various studies have highlighted the relationship between 
chromatin maintenance and virulence of eukaryotic pathogens. Single cell eukaryotic 
pathogens must adapt to various environmental stimuli to successfully propagate in 
the mammalian host, evade attacks from its immune system and ensure future 
transmission to the next host. These processes often require dramatic morphological 
changes, expression of virulence-associated genes, and repair of damaged DNA 
caused by the hostile host environment. Many of these events involve chromatin 
alterations that are crucial for successful pathogenesis. There are several thorough and 
current reviews on chromatin modification of eukaryotic single cell pathogens such as 
Plasmodium falciparum (Cui and Miao, 2010; Lopez-Rubio et al., 2007), 
Trypanosoma brucei (Figueiredo et al., 2009; Lopez-Rubio et al., 2007) and 
Toxoplasma gondii (Dixon et al., 2010) that establish precedence for chromatin 
functions affecting pathogenesis. It is now also clear that chromatin maintenance is 
important for virulence in fungal pathogens, specifically Candida albicans (discussed 
below). 
C. albicans is the most prevalent human fungal pathogen (Pfaller and Diekema, 
2007). As ubiquitous opportunistic pathogens, Candida species are the fourth leading 
cause of hospital-acquired infections (Pfaller and Diekema, 2007), often stemming 
from implanted medical devices or organ transplants (Neofytos et al., 2010). In 
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healthy individuals, C. albicans adheres to and colonizes the mucosal lining of the 
human gut as a commensal organism. If the ecological balance is disturbed through 
the use of antibiotics or severe immuno-deficiency, C. albicans can overgrow and 
cause irksome but benign mucosal infections such as vaginitis, diaper rash or oral 
thrush. However, Candida species can also cause life-threatening infections. Fungal 
cells can spread into the circulatory system, leading to systemic candidiasis 
(candidemia). Although very rare, the mortality rate for systemic candidiasis is as 
high as 49%, despite anti-fungal treatment (Gudlaugsson et al., 2003). Furthermore, 
resistance to the currently available anti-fungal medications is rising (Cannon et al., 
2007; Cowen et al., 2002; Pfaller et al., 2011). This situation makes candidiasis 
infections a significant public health concern, and thus novel anti-fungal drug targets 
are of great interest. Most anti-Candida drugs target cell membrane or cell wall 
synthesis, so identification of alternative physiological pathways that affect 
pathogenicity is an important goal for biomedical research. 
With the intention of obtaining novel anti-fungal drugs, specifically against C. 
albicans, I have targeted a chromatin maintenance protein called Rtt109. Rtt109 has 
no functional homologues outside of the fungal kingdom and was first intensely 
studied for its crucial role in resistance to DNA damage in yeast. As a histone-
modifying enzyme, Rtt109 represents a novel pathway to target for anti-fungal drug 
development. In this dissertation, I establish the role of Rtt109 in pathogenicity in 
vivo and characterize the first Rtt109 chemical inhibitor through in vitro enzymology 
studies. 
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 2. Aspects of chromatin that promote pathogenicity through transcription 
regulation 
2.1 Overview 
 C. albicans is a dimorphic fungus. Under normal laboratory conditions (30°C, 
rich media), the cells grow with a budded yeast morphology. In response to various 
triggers, such as serum, nitrogen starvation or DNA damage, the cells filament to 
form pseudohyphae or true hyphae forms (Kumamoto and Vinces, 2005; Shi et al., 
2007; Sudbery, 2011). The ability to change morphologically is important for 
pathogenicity, suggesting that the different shapes and characteristics of these cells 
are beneficial in different niches during infection (Reviewed in (Gow et al., 2012; 
Romani et al., 2003)). For instance, filamentous cells are best suited to infiltrate tissue 
(Brand, 2012; Gow et al., 2012). As a result of cellular morphology, C. albicans form 
different colony shapes on agar. Morphological changes, specifically between yeast 
and filamentous forms are regulated through transcription. A number of hyphae-
specific genes encoding structural proteins and transcription factors have been 
identified that control this transition (reviewed in (Calderone and Fonzi, 2001; Ernst, 
2000; Whiteway and Bachewich, 2007)). Several studies have highlighted the role of 
chromatin modification to promote regulation of these different transcription states 
(see below). 
 
2.2 Set1 Methyltransferase 
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The first account of a histone modifying enzyme affecting C. albicans 
pathogenicity was discovered in an interesting fashion. Cheng et al. performed an 
immunological screen using sera from HIV-positive patients suffering from oral 
candidiasis against proteins expressed from a C. albicans genomic library (Cheng et 
al., 2003). The histone methyltransferase (HMT), Set1, was one of three immunogens 
that were identified. A unique species-specific 208 amino acid N-terminus domain 
proved to be immunogenic in humans, allowing for this discovery (Raman et al., 
2006). 
Set1 is a well-conserved HMT that targets histone H3 lysine 4 (H3K4) resulting 
in mono-, di-, or tri- methylation (Briggs et al., 2001). Set1 and H3K4-methylation 
are generally associated with active gene transcription (Guillemette et al., 2011), but 
are also involved in DNA damage resistance (Faucher and Wellinger, 2010). 
Although, C. albicans set1-/- mutants lose all detectable H3K4 methylation, these 
cells exhibit few morphological phenotypes except for hyperfilamentation when 
embedded in agar (Raman et al., 2006). However, set1-/- mutants are significantly less 
successful at adhering to mammalian cells in vitro, at colonizing organs in mice, and 
at causing mortality in murine systemic candidiasis (Raman et al., 2006). 
 
2.3 Gcn5-containing complexes 
Gcn5 is a well-conserved histone acetyl-transferase that provides HAT activity to 
several transcription activator complexes such as SAGA and ADA (Brownell et al., 
1996). Gcn5-mediated acetylation also promotes genome stability by catalyzing 
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PTMs related to nucleosome assembly (Burgess et al., 2010). In C. albicans, 
inactivation of the SAGA/ADA complexes, by eliminating the core subunit Ada2, 
results in decreased histone H3 lysine 9 (H3K9)- acetylation (a mark of active 
transcription for many inducible loci), increased sensitivity to oxidative stress and 
fluconazole, and a defective response to in vitro filamentation stimuli (Pukkila-
Worley et al., 2009; Sellam et al., 2009). Ada2 occupies the promoter of many 
oxidative stress-induced and fluconazole-induced genes. Accordingly, ada2-/- cells 
display reduced transcription of these genes. As a result, these mutants cause less 
mortality in mice and Caenorhabditis elegans infection models (Pukkila-Worley et 
al., 2009; Sellam et al., 2009). 
Likewise, in the fungal pathogen Cryptococcus neoformans, Gcn5 is essential for 
pathogenicity in the murine inhalation model of cryptococcosis (O'Meara et al., 
2010). Gcn5 mutant strains display increased sensitivity to H2O2 and elevated 
temperatures, but not to other stresses such as starvation or high salt (O'Meara et al., 
2010). Most interestingly, gcn5 mutants are deficient in capsule formation, the 
mechanism by which this organism protects itself from being phagocytosed (O'Meara 
et al., 2010). 
 
2.4 Sirtuin deacetylases in heterochromatin silencing 
A major reoccurring theme in unicellular eukaryotic pathogens is the 
regulation of genes located in heterochromatin that encode variant surface proteins 
(Merrick and Duraisingh, 2006). Heterochromatin is a region of the genome that is 
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stably silenced because of heritable chromatin conformation. Certain pathogens, such 
as Plasmodium falciparum and Trypanosoma brucei, evade the immune system by 
expressing only one of numerous variants of a single coat protein gene, via a 
mechanism termed allelic exclusion (reviewed in (Lopez-Rubio et al., 2007; 
Verstrepen and Fink, 2009)). In both these organisms, the regulated loci are sub-
telomeric and regulation is dependent on the formation of heterochromatin. In P. 
falciparum, this allelic exclusion requires the sirtuin-family histone deacetylase, Sir2 
and in T. brucei, Rap1, the telomeric DNA binding protein is required (Duraisingh et 
al., 2005; Freitas-Junior et al., 2005; Tonkin et al., 2009; Yang et al., 2009). In C. 
albicans, loss of heterochromatin silencing through homozygous deletion of SIR2 
causes unstable inheritance of colony morphology (Pérez-Martín et al., 1999). Thus 
far, no transcriptional effects of SIR2 deletion have been reported for C. albicans. 
Candida glabrata, another human fungal pathogen, possesses two sub-
telomeric gene clusters that code for seven Epithelia Adhesin (EPA) membrane 
proteins (Castaño et al., 2005; De Las Peñas et al., 2003). EPA1 is the only EPA gene 
expressed in laboratory cultured cells and is essential for adhesion to mammalian 
cells in vitro. However, epa1-/- cells are not deficient in pathogenicity (Cormack et al., 
1999). Other EPA genes (EPA2-6) are silent in cultured cells but can be de-repressed 
upon loss of telomeric heterochromatin silencing by deleting SIR2, SIR3 or RAP1 (De 
Las Peñas et al., 2003; Domergue et al., 2005). Interestingly, silencing of the EPA6 
genes is determined by the amount of nicotinic acid (NA) in the environment 
(Domergue et al., 2005). C. glabrata is auxotrophic for NA and therefore cannot 
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synthesize NAD+ to allow NAD+-dependent sirtuin deacetylases, like Sir2, to 
function. EPA6 is selectively expressed during the mouse model for C. glabrata 
urinary tract infection, but not during systemic candidiasis or in culture (Domergue et 
al., 2005). Tissue culture media provides sufficient NA, however, urine does not. This 
explains why EPA6 is selectively expressed in NA depleted environment and why 
deletion of the EPA cluster leads to significant avirulence in the case of urinary tract 
infections. In conclusion, there is a direct link between de-repression of sirtuin-
mediated silenced virulence genes with the appropriate environmental cues in C. 
glabrata. 
 
2.5 SWI/SNF and Chromatin remodeling  
 Chromatin maintenance not only involves histone modification, but it also 
involves chromatin remodeling to change local nucleosome density. The multi-
subunit complex, SWI/SNF promotes transcription of inducible genes by sliding and 
evicting nucleosomes on DNA, providing access for transcriptional machinery (Côté 
et al., 1994; Kwon et al., 1994). Deletion of either SWI1, encoding DNA 
binding/transcription co-activator, or SNF2, encoding the ATPase subunit, results in 
complete loss of pathogenicity in murine systemic candidiasis (Mao et al., 2006). In 
culture, these mutants cannot express hyphae (filamentation)-specific genes in 
response to stimuli such as serum or nutrient starvation, and as a result do not 
filament (Mao et al., 2006). Normally, Snf2 is recruited to hyphae-specific genes 
(HWP1, ALS3, ECE1) under these conditions by the combined action of the NuA4 
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HAT complex and the hyphae-specific transcription factor Efg1 (Lu et al., 2008). Via 
ChIP assays, both Efg1 and NuA4 can be found at these hyphae-specific genes 
regardless of cellular morphology (Lu et al., 2008). However, NuA4 requires Efg1 to 
reside at these promoters, indicating that Efg1 recruits NuA4 and that this in turn 
recruits SWI/SNF to allow transcription of hyphae-specific genes (Lu et al., 2008). 
Therefore, the hyphae-specific transcription factor Efg1, which promotes 
pathogenicity in murine systemic candidiasis (Lo et al., 1997), requires both a histone 
modification and a chromatin remodeling to transcribe filament-specific genes. It is 
likely that a multitude of chromatin proteins contribute to other virulence-related gene 
expression by similar mechanisms. 
 
2.6 Regulation of white-opaque switching 
 The clinical isolate WO-1 C. albicans “switching strain” exists in two 
morphological states: round cells that form white round colonies and elongated cells 
that form opaque flat colonies (Slutsky et al., 1987). (These morphological 
phenotypes are distinct from those described above in sir2-/- cells (Pérez-Martín et al., 
1999)). Increased pathogenicity is attributed to either cell type depending on the site 
of infection, hinting that phenotypic switching could be a virulence factor to better 
colonize distinct environments (reviewed in (Morschhäuser, 2010; Soll, 2009)). 
White-opaque switching, regulated by transcriptional feedback loops and the master 
regulator WOR1, remain stable over many generations (reviewed in (Lohse and 
Johnson, 2009; Morschhäuser, 2010). This type of stable inheritance suggested that 
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some aspects of chromatin regulation might be involved, and therefore several 
investigators have directly tested whether histone-modifying enzymes affect white-
opaque phenotypic switching (Hnisz et al., 2009; Klar et al., 2001; Srikantha et al., 
2001). Notably, destabilization of the SET3C HDAC complex, by deleting the genes 
encoding either core subunits SET3 or HOS2, decreases white-opaque switching in 
WO-1 strains. These set3-/- and hos2-/- cells also exhibit hypersensitivity to 
filamentation stimuli such as low nutrient agar (Lee’s media) or elevated growth 
temperature (37°C) (Hnisz et al., 2010; Hnisz et al., 2009). Despite having a Set 
domain common to methyltransferase enzymes, Set3 doesn’t seem to have histone 
methyltransferase activity. Instead, the SET3C complex possesses HDAC activity 
through the Hos2 and Hst1 subunits. In S. cerevisiae, this complex has a primary role 
in repressing genes involved in sporulation, a meiotic process that does not occur in 
C. albicans (Pijnappel et al., 2001). Nevertheless, set3-/- C. albicans are 
hyperfilamentous and cause significantly less mortality during murine systemic 
candidiasis (Hnisz et al., 2010). SET3C is believed to be the homologue of human 
HDAC3/SMRT, and it will be of great interest to determine the virulence-associated 
loci that are regulated by this complex. 
 
3. Aspects of chromatin that promote pathogenicity through genome stability 
3.1 Overview 
 In collaboration with the receptor-mediated immune system, the innate 
immune system plays an integral part in clearing mammals of pathogens. Phagocytes, 
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such as macrophages and neutrophils, engulf antibody-coated or complement-coated 
microbes into a membrane-bound compartment called a phagosome and eventually 
subject them to various toxic molecules (Pereira and Hosking, 1984) (reviewed in 
(Mansour and Levitz, 2002; Netea et al., 2008)). These toxins include reactive oxygen 
species (ROS) such as hydroxyl radicals (•OH), superoxide anions (O2-) and 
hydrogen peroxide (H2O2) that are generated through oxidative burst by the 
membrane-bound NADPH-oxidase enzyme (reviewed in (Missall et al., 2004)). In 
vitro, generation of ROS by phagocytes promotes C. albicans killing (Ferrante, 1989; 
Frohner et al., 2009; Hu et al., 2006; Lopes da Rosa et al., 2010; Sasada and Johnston, 
1980; Sasada et al., 1987; Thompson and Wilton, 1992). In vivo, mice that are 
deficient in the NADPH-oxidase enzyme as a model for chronic granulomatous 
disease, an illness that leads to elevated susceptibility to mycosal infections, are more 
susceptible to pulmonary and systemic candidiasis (Aratani et al., 2002a; Aratani et 
al., 2002b). Accordingly, C. albicans mutant cells that lack the superoxide dismutase 
or catalase enzymes to neutralize these toxic molecules (sod5-/- and cta1-/- mutants, 
respectively) are less resistant to macrophages and less pathogenic in murine systemic 
candidiasis (Frohner et al., 2009; Martchenko et al., 2004; Wysong et al., 1998). 
Together, these investigations established that proteins required for fungi to withstand 
ROS-mediated damage are important for pathogenesis. Furthermore, because ROS 
directly damage DNA, genotoxic stress is likely to be a factor in these situations. 
Multiple DNA repair pathways are crucial for C. albicans pathogenesis. 
Defects in homologous recombination in rad52-/- mutants and in non-homologous end 
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joining in lig4-/- mutants causes avirulence in murine systemic candidiasis (Chauhan 
et al., 2005). Further, multiple DNA repair genes, along with oxidative stress genes, 
are up-regulated when C. albicans comes into contact with macrophages in vitro 
(Lorenz et al., 2004). However, C. albicans mutants that lack base excision repair 
(BER) proteins (apn1-/-, ntg1-/- and ogg1-/-) are not hypersensitive to H2O2 or exposure 
to macrophages (Legrand et al., 2008). One interpretation for the latter results is that 
overlapping functionality with other proteins results in minimal phenotypes in cells 
lacking a single BER protein (Legrand et al., 2008). In any case, these results support 
the notion that the ability to survive genotoxic stress by C. albicans is indeed a 
virulence factor. 
To evade killing in the phagosome, C. albicans changes morphology from 
budded cells to hyphal or pseudohyphal filaments, thereby rupturing out of the 
phagocyte (reviewed in (Calderone and Fonzi, 2001; Romani et al., 2003; Vázquez-
Torres and Balish, 1997). Various environmental stimuli can induce filamentation in 
vitro, including genotoxic stress caused by DNA damage or DNA replication blocks 
(Bai et al., 2002; Nasution et al., 2008; Shi et al., 2007). Filamentation from 
replication stress or DNA damage depends on the checkpoint proteins Rad53 and 
Rad9 (Shi et al., 2007), linking the ability to escape phagocytes to signaling pathways 
that sense and respond to DNA damage (Shi et al., 2007). In sum, the mechanisms for 
sensing DNA damage, escaping the phagosome, and repairing DNA damage 
generated by host-generated ROS are interconnected in C. albicans and are 
imperative for successful pathogenesis. 
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 3.2 Genotoxic stress and histone post-translation modification 
Histone post-translation modifications (PTM) are frequently studied as marks 
associated with gene expression. However, their contributions to DNA damage 
checkpoint signaling and DNA repair are also substantial (Allard et al., 2004; Moore 
and Krebs, 2004). A notable example is acetylation of histone H3 lysine 56 (H3K56), 
synthesized by the histone acetyl-transferase, Rtt109 (Collins et al., 2007; Driscoll et 
al., 2007; Han et al., 2007a) (further discussed in detail in section 4 and in Chapter 2). 
Our laboratory was first to demonstrate that loss of H3K56 acetylation via 
deletion of RTT109 in C. albicans strikingly reduces mortality in mice subjected to 
systemic candidiasis (Lopes da Rosa et al., 2010) (see Chapter 2). Furthermore, 
rtt109-/- cells are incapable of efficiently colonizing the kidneys during acute (24 
hours) or prolonged (20 days) infections (Lopes da Rosa et al., 2010; Wurtele et al., 
2010). Notably, the poor pathogenicity of rtt109-/- cells correlates with an inability to 
withstand phagocyte-generated ROS (Lopes da Rosa et al., 2010). Although, rtt109-/- 
cells are significantly more susceptible to macrophages in vitro than wild-type cells, 
preventing macrophage-generated ROS renders rtt109-/- mutants equally resistant as 
wild-type cells (Lopes da Rosa et al., 2010). These data demonstrate that the 
genotoxic stress protection provided by Rtt109 and H3K56ac is important for C. 
albicans to survive phagocytosis by macrophages, providing a mechanistic 
explanation for the defect in pathogenesis. 
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 In C. albicans, the NAD+- dependent sirtuin HDAC, HST3, is an essential 
gene and is solely responsible for hydrolyzing acetylated H3K56 (H3K56-ac) 
(Wurtele et al., 2010). Heterozygous hst3+/- mutants are hypersensitive to genotoxic 
stress (Wurtele et al., 2010). Deletion of both RTT109 alleles prevents the hst3-/- lethal 
phenotype, indicating that hyper-accumulation of H3K56-ac is lethal in C. albicans 
(Wurtele et al., 2010). Accordingly, nicotinamide (NAM), an inhibitor of NAD+-
dependent HDACs, is toxic to C. albicans and a variety of other human pathogenic 
fungi including several other Candida species and Aspergillus fumigatus (Wurtele et 
al., 2010). Interestingly, hyper-accumulation of H3K56-ac is not fatal in 
Saccharomyces cerevisiae, as hst3Δ, hst4Δ mutants are viable (Celic et al., 2006; 
Maas et al., 2006). 
Rtt109 affects multiple processes in pathogenic fungi, because it also affects 
morphological white-opaque “switching” events (described above) in Candida 
albicans (Stevenson and Liu, 2011). rtt109-/- opaque cells are not stable and have an 
increased switching frequency to white cells. Conversely, increasing H3K56-ac levels 
by deletion of a copy of HST3 or exposure to sub-lethal concentrations of NAM 
promotes opaque formation (Stevenson and Liu, 2011). 
 
3.3 Genome plasticity and the spindle assembly checkpoint 
 A major function of chromatin modification and remodeling is to ensure 
genome stability, specifically the proper inheritance of genomic information in 
macro-structural units called chromosomes. C. albicans, however, is notorious for 
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generating aneuploidy in culture (Ahmad et al., 2008; Selmecki et al., 2005). In 
certain cases, genome instability is purposely beneficial to C. albicans. For example, 
C. albicans readily loses a copy of chromosome 5 (Chr5) in order to survive on the 
alternative carbon sources, sorbose (Janbon et al., 1998; Rustchenko et al., 1994). C. 
albicans also manipulates Chr5 to attain resistance to fluconazole, a clinically used 
anti-fungal drug. Two extra arms of Chr5L flanked by a neo-centromere (5 i(5L)) is 
generated and stably perpetuated to provide additional copies of ergosterol synthesis 
genes (Selmecki et al., 2006). Another remarkable example is that Candida 
centromeres can be moved to neighboring locations under the appropriate genetic 
selection (Ketel et al., 2009).  
It is unclear how these frequent chromosome alteration events are regulated. 
One possibility could have been a relaxed spindle assembly checkpoint. The spindle 
assembly checkpoint ensures that all kinetochores are properly attached to a spindle, 
prior to anaphase, to ensure accurate segregation of chromosomes to each daughter 
cell (reviewed in (McAinsh et al., 2003)). Bai et al. hypothesized that because 
pathogenic fungi face extensive chromosomal damage from phagocyte-generated 
ROS, the spindle assembly checkpoint pathway would be imperative for 
pathogenicity (Bai et al., 2002). Indeed, homozygous deletion of MAD2, a protein 
essential for SAC function, renders C. albicans hypersensitive to H2O2 and results in 
complete loss of virulence in murine systemic candidiasis (Bai et al., 2002). 
Therefore, like the DNA damage checkpoint (Shi et al., 2007), the spindle assembly 
checkpoint in C. albicans functions to promote pathogenesis. However, these findings 
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do not support a relaxed spindle assembly checkpoint as the source of genome 
plasticity in C. albicans. 
 
4. Rtt109 (Regulator of Ty1 Transposition 109) 
4.1 Function of Rtt109 
Rtt109 was not initially recognized as an enzyme based on primary sequence 
similarity to other histone acetyl-transferase (HAT) enzymes. In fact, Rtt109 was first 
identified in a screen for repressors of Ty1 transposition, where disruption of the 
previously uncharacterized open reading frame caused elevated transposition events 
(Scholes et al., 2001). Rtt109 was eventually implicated in H3K56 acetylation via 
genome-wide Western blot surveys of the yeast deletion collection for mutants that 
lack H3K56-ac (Han et al., 2007a; Schneider et al., 2006). 
Rtt109 has several distinguishing properties; it has no close sequence 
homologues outside of the fungal kingdom and requires one of two histone 
chaperones, Vps75 or Asf1, to stimulate its catalytic activity (Albaugh et al., 2010; 
Kolonko et al., 2010; Recht et al., 2006; Tsubota et al., 2007). In vivo, Rtt109 is 
solely responsible for H3K56 acetylation, and requires the eukaryotically conserved 
histone chaperone Asf1 (anti-silencing factor 1) for catalysis (Recht et al., 2006). 
Rtt109 also partially contributes to cellular levels of N-terminal tail modifications, 
H3K9, H3K23 and H3K27 acetylation (marks associated with newly deposited 
histone), and requires the NAP (nucleosome assembly protein) family histone 
chaperone, Vps75 to do so (Berndsen et al., 2008; Fillingham et al., 2008). In vitro, 
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Rtt109-Asf1 are only effective on H3 in the context of an H3-H4 dimer or tetramer 
(Han et al., 2007b; Tsubota et al., 2007), whereas histone H3 alone or H3 peptides are 
not efficiently used as substrates (unpublished data, JLS). This limitation is most 
likely due to the interaction between Asf1 and H4 domains of the H3-H4 dimer as 
observed in the co-crystal structure (English et al., 2006). In vitro, Rtt109-Vps75 
complexes are very efficient at catalyzing acetylation of all known Rtt109 targets on 
tetramers, histone H3 alone, and N-terminal H3 peptides. However, Rtt109, 
regardless of activating cofactor, cannot efficiently acetylate H3K56 on nucleosomes 
(Han et al., 2007c). 
Rtt109 has a very strong affinity for Vps75; Kd = 10 ± 2 nM (Albaugh, 2010). 
Rtt109-Vps75 complexes are readily purified from yeast or co-expressing E. coli 
cells. However, Rtt109 has a much weaker interaction with Asf1, and Rtt109-Asf1 
complexes have only been co-purified from yeast using cross-linkers (Han et al., 
2007b). The strong interaction with Vps75 may be beneficial to Rtt109, as it 
stabilizes the Rtt109 protein in vivo (Fillingham et al., 2009). Vps75 also partially 
escorts Rtt109 into the nucleus via its nuclear localization signal (Keck and 
Pemberton, 2011). Rtt109 itself does not possess a canonical NLS and the role of 
Asf1 or histones have not been addressed as a potential nuclear escort partner. 
 
4.2 Description of H3K56 
 Most modifications occur on N-terminal histone tails that protrude outside the 
DNA gyres of the nucleosome. The globular domain of histones is comprised of 3 α- 
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helical histone fold domains each separated by an unstructured loop. Histone H3 
additionally has an α-helix between the N-terminal tail and the first histone fold 
domain. This region makes extensive interactions with DNA, in contrast to the N-
terminal tails, insinuating that these residues are relevant to nucleosome stability and 
flexibility. Through mass spectrometry analysis and genetic manipulations novel 
globular domain modifications were discovered (Garcia et al., 2007; Hyland et al., 
2005; Xu et al., 2005; Zhang et al., 2003). 
By mass spectrometry, 28% of H3 in asynchronous populations of S. 
cerevisiae are H3K56- acetylated (Xu et al., 2005). H3K56 is the first residue of the 
α-N-helix that interacts with DNA after the N-terminal tail. Lysine 56 interacts with 
the phosphodiester backbone of DNA through a water molecule at the entry and exit 
points of the nucleosome (Davey et al., 2002; Luger et al., 1997). Acetylation of 
H3K56 would presumably disrupt the electrostatic interaction between the positively 
charged histone protein and the negatively charged DNA backbone. Mutations that 
reverse the positive charge of lysine to a negative charge (H3k56e) are lethal 
(Erkmann and Kaufman, 2009). Acetylation of H3K56 does not alter the structure of 
the nucleosome, as observed through crystal structure studies (Watanabe et al., 2010). 
However, acetylation of H3K56 results in an overall less dense chromatin structure 
(Driscoll et al., 2007; Kamieniarz and Schneider, 2009; Masumoto et al., 2005; 
Neumann et al., 2009; Xu et al., 2007b). In accordance, in vitro studies show that 
formation of nucleosome arrays is not affected by K56 acetylation, but interactions 
between nucleosome arrays are disrupted (Watanabe et al., 2010). 
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  In Saccharomyces cerevisiae, all newly synthesized histones are acetylated 
on H3K56, resulting in genome-wide distribution during S-phase (Celic et al., 2006; 
Kaplan et al., 2008; Maas et al., 2006; Masumoto et al., 2005). H3K56 is also 
abundant in other yeast species such as Schizosaccharomyces pombe, C. albicans and 
Pneumocystis carinii (Kottom et al., 2011; Lopes da Rosa et al., 2010; Recht et al., 
2006; Xhemalce et al., 2007). Genome-scale views across the budding yeast cell 
cycle detects H3K56-ac in waves following DNA replication forks and also at sites of 
replication-independent histone exchange, demonstrating that this is a short-lived 
mark of new histone incorporation (Kaplan et al., 2008; Masumoto et al., 2005). The 
rapid decay of this mark depends on sirtuin (Sir2 family) NAD+-dependent histone 
deacetylase (HDAC) enzymes, Hst3 and Hst4 in S. cerevisiae (Celic et al., 2006; 
Maas et al., 2006). Outside of S-phase, H3K56-ac is incorporated via histone turnover 
during transcription elongation at actively transcribed loci (Schneider et al., 2006) 
and especially at inducible loci (Rufiange et al., 2007). 
 
4.3 Phenotypes associated to defects in H3K56 acetylation 
Point mutation of the H3K56 residue into an amino acid that cannot be 
acetylated (H3K56R) or that mimics constitutive acetylation (H3K56Q) leads to 
hypersensitivity to genotoxic stress and DNA damaging agents, including endogenous 
DNA damage (Hyland et al., 2005; Masumoto et al., 2005). Accordingly, the proteins 
that synthesize (Rtt109 & Asf1) and hydrolyze (Hst2, Hst3 and Hst4) H3K56-ac are 
required for genotoxic stress resistance in S. cerevisiae, Schizosaccharomyces pombe 
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and C. albicans (Driscoll et al., 2007; Han et al., 2007a; Lopes da Rosa et al., 2010; 
Recht et al., 2006; Schneider et al., 2006; Wurtele et al., 2010; Xhemalce et al., 
2007). Deletion of the hydrolyzing HDACs leads to frequent chromosome loss in S. 
cerevisiae (Celic et al., 2006; Thaminy et al., 2007) and is lethal in C. albicans 
(Wurtele et al., 2010), demonstrating the importance of H3K56-ac transient nature. 
Nevertheless, H3K56-ac abundance is prolonged past S-phase under DNA damaging 
conditions until DNA has been repaired (Maas et al., 2006; Masumoto et al., 2005). 
rtt109 mutants are not DNA damage checkpoint deficient (Driscoll et al., 2007; 
Masumoto et al., 2005). They activate the DNA damage and replication checkpoints 
through the Rad53 kinase followed by DNA repair as in wild-type (Chen and Tyler, 
2008; Driscoll et al., 2007). However, histone deposition after a single site-specific 
double-strand break repair is slowed in rtt109Δ cells (Chen and Tyler, 2008; Williams 
et al., 2008) indicating that H3K56-ac plays a role in restoring chromatin after 
damage.  
In general, histone turnover is slowed in rtt109 and asf1 mutants (Kaplan et 
al., 2008) because H3K56-ac enhances histone deposition onto DNA via the 
replication-dependent histone chaperones CAF-1 (chromatin assembly factor 1) and 
Rtt106 (Li et al., 2008; Su et al., 2012; Zunder et al., 2012). rtt109Δ experience 
spontaneous DNA damage, marked by elevated histone H2A(S129) phosphorylation 
and Rad52 foci (Driscoll et al., 2007; Han et al., 2007a; Lopes da Rosa et al., 2010). 
Replication fork stability is compromised in cells unable to acetylate H3K56. Stalled 
replication forks collapse when cells are depleted of deoxynucleotides by the effects 
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of the S-phase blocking agent hydroxy urea (HU) (Han et al., 2007b; Recht et al., 
2006). However, these mutants can recover from transient S-phase blocks, as opposed 
to direct DNA damage caused by camptothecin or methyl methane sulfonate (Wurtele 
et al., 2012). In addition, cells unable to acetylate H3K56 have increased 
accumulation of extrachromosomal rDNA circles (Han et al., 2007b) a consequence 
of natural replication fork barriers on rDNA repeats that would be problematic for 
unstable stalled replication forks. Follow up on these findings may clarify a role for 
H3K56-ac and Rtt109 in DNA damage versus DNA replication. 
 
4.4 H3K56-ac in mammalian cells 
Detection of H3K56-ac in humans is controversial, but clearly much less 
abundant than in yeast, if present at all (Garcia et al., 2007; Xu et al., 2005; Yu et al., 
2012). Early mass spectrometry analysis of HeLa cells (Henrietta Lacks’ cervical 
cancer cell line) approximated that 1% of H3 were K56- acetylated (Xie et al., 2009). 
However, 0.8% of H3K56 is reported to be methylated, as detected by the same 
technique, making the specific identification of the modification technically 
ambiguous (Garcia et al., 2007; Yu et al., 2012). In contrast, other well-described 
histone acetylation marks in HeLa cells occur on 3.8- 22.9% of H3 (Horwitz et al., 
2008). A later re-examination of H3K56-ac in HeLa and K562 (a human 
erythroleukemic cell line) cell lines using more stringent and controlled 
quantifications for mass spectrometry showed that only 0.03% of H3 possessed the 
modification. The level of acetylation did not change despite treatment with various 
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HDAC inhibitors (Drogaris et al., 2012). Additionally, the same laboratory showed 
that misleading results can arise from anti-H3K56-ac antibody cross-reaction when 
HDAC inhibitors increased acetylation marks on other lysine residues in the context 
of non-H3K56 peptides (Drogaris et al., 2012). Issues with antibody specificity had 
previously been reported specifically when H3K56-ac was detected on recombinant 
H3 (Ozdemir et al., 2006). Furthermore, transduction of HeLa cells with inducible 
yeast RTT109 and ASF1 lentivirus yields no detectable H3K56-ac signal by Western 
blot using our specific anti- H3K56-ac anti-serum, despite appropriate expression of 
the two proteins and the addition of various HDAC inhibitors (unpublished data, 
JLS). Overall, these data suggest that H3K56ac is not a prevalent modification in 
humans. Nevertheless, various studies utilizing antibodies for Western blot and 
immuno-fluorescence detection in human cells have associated H3K56-ac with cell 
differentiation (Dovey et al., 2010; Dutta et al., 2010; Xie et al., 2009), DNA damage 
(Battu et al., 2011; Miller et al., 2010; Tjeertes et al., 2009; Vempati, 2011; Vempati 
et al., 2010; Yuan et al., 2009) and cell-specific transcription regulation (Kong et al., 
2011; Lo et al., 2011). What is not contested is that a homologue of Rtt109 does not 
exist in the human genome. The consensus is that both the well conserved eukaryotic 
HAT, Gcn5 and the mammalian p300 are responsible for H3K56 acetylation in 
human cells (Kong et al., 2011; Tjeertes et al., 2009; Vempati et al., 2010). Although, 
the efficiency of p300 activity towards H3K56 compared to H4 N-terminal tail 
residues in vitro is extremely poor (unpublished data, JLS). 
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5. A HAT inhibitor as a novel anti-fungal agent 
5.1 HAT families 
There are three known families of HAT enzymes, based on primary sequence: 
p300/CBP, GNAT (Gcn5- related N-acetyl transferase) and MYST (MOZ, 
Ybf2/Sas3, Sas2, Tip60). Rtt109 has no primary sequence similarity to the HAT 
families and the canonical Motif A (acetyl coA binding pocket) of HATs is 
unrecognizable through sequence analysis in Rtt109. Our laboratory, as well as 
others, first reported histone acetyl-transferase activity of Rtt109 through biochemical 
assays (Collins et al., 2007; Driscoll et al., 2007; Han et al., 2007a; Tsubota et al., 
2007; Xhemalce et al., 2007). Later on, through crystal structure studies, it became 
evident that the central core region of Rtt109 is structurally similar to that of the well-
conserved eukaryotic Gcn5 HAT (Lin and Yuan, 2008) and that overall Rtt109 shares 
a three dimensional fold with p300 (Stavropoulos et al., 2008; Tang et al., 2011; Tang 
et al., 2008), a HAT only conserved in mammals. Similar to p300, Rtt109 also uses 
auto-acetylation to activate catalysis (Karanam et al., 2006; Thompson et al., 2004). 
Due to these similarities, some laboratories group Rtt109 with the p300/CBP family. 
However, the polarity and chemistry of their active sites (Marmorstein and Trievel, 
2009; Wang et al., 2008) and the catalytic mechanisms of Rtt109 and p300 are 
distinct (Albaugh et al., 2010; Berndsen and Denu, 2008; Kolonko et al., 2010; Lin 
and Yuan, 2008; Tang et al., 2008). 
 
5.2 HAT enzymatic mechanisms 
24
Thus far, HAT catalysis events all involve de-protonation of the target histone 
lysine residue, followed by its nucleophilic attack of the acetyl group on acetyl 
coenzyme A (Hodawadekar and Marmorstein, 2007; Marmorstein and Trievel, 2009). 
Initial studies of Esa1, a MYST family HAT, suggested a ping-pong mechanism, 
which involves a covalent link between the acetyl group and the enzyme prior to 
nucleophilic attack by the de-protonated histone lysine (Yan et al., 2002) (Figure 1.1). 
Current evidence, however, supports that both GNAT and MYST family enzymes use 
a sequential mechanism involving a ternary intermediate complex where both 
substrates are simultaneously associated to the enzyme without formation of a 
covalent bond (Figure 1.1) (Berndsen et al., 2007; Tanner et al., 2000; Tanner et al., 
1999). p300, on the other hand, operates a Theorell-Chance (“hit-and- run”) 
mechanism that involves formation of an intermediate enzyme-acetyl coenzyme A 
complex, followed by transient association with the protein substrate (Figure 1.1) 
(Liu et al., 2008). In this case, a ternary intermediate complex is not formed. Rtt109 
follows a random sequential mechanism similar to that observed for Gcn5 and Esa1. 
Specifically, either substrate can bind Rtt109 in any order to form a ternary complex 
for catalysis (Albaugh et al., 2010). 
Rtt109 enzymology is intriguing. As an enzyme Rtt109 is very inefficient in 
the absence of its histone chaperone cofactors. Rtt109 depends on histone chaperones 
Asf1 or Vps75 to increase catalytic efficiency [Kcat/ Km (M-1 S-1) = 1.5 x 103 
(Rtt109); 8.4 x 104 (Rtt109-Vps75); 2 x 104 (Rtt109-Asf1)] (Berndsen et al., 2008; 
Tsubota et al., 2007). The chaperones have a less significant effect on Km for 
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tetramers, which is consistent with Rtt109’s ability to bind histones directly, although 
with 10 fold less affinity than Vps75 or Asf1 (Han et al., 2007c; Park and Luger, 
2008). The role of the chaperones may indeed be to solely stimulate catalysis, as 
opposed to simply recruiting histones.  
Additionally, Rtt109 must be acetylated at lysine 290 to be functional 
(Stavropoulos et al., 2008). Rtt109 auto-acetylates itself intra-molecularly and 
independently of histone chaperones (Albaugh et al., 2011). K290 auto-acetylation 
occurs 50 times slower than histone acetylation (Albaugh et al., 2011). Mutation of 
K290 on Rtt109 to prevent acetylation increases the Km and the Kd for acetyl-
coenzyme A by ≥ 10 fold (Albaugh et al., 2011). Attempts to investigate the status of 
Rtt109-K290 as a means of H3K56-ac regulation throughout the cell cycle were 
unsuccessful due to low antibody sensitivity (unpublished data, JLS). It would be 
very interesting to determine if and how Rtt109-K290 acetylation regulates H3K56-ac 
status in vivo. 
 
5.3 HAT inhibitors and potential applications 
 Because of their strong impact on genome function, the relationship between 
human diseases and histone acetylation is an active topic of investigation (Dekker and 
Haisma, 2009; Timmermann et al., 2001). However, advances in chemotherapeutic 
developments are most promising for histone de-acetylase (HDAC) inhibitors 
(Dokmanovic et al., 2007). Only few studies have focused on identifying HAT 
inhibitors as a novel source of chemotherapeutic drugs (Dekker and Haisma, 2009). 
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Several synthetic and natural compounds have been characterized as HAT 
inhibitors (Reviewed in (Cole, 2008; Dekker and Haisma, 2009)). Acetyl-coA bi-
substrate adducts are cell-impermeable transition state and product analogs that can 
inhibit HAT enzyme activity in vitro (Lau et al., 2000). However, neither lysine-
coenzyme A nor an H3K56-coenzyme A bisubstrate analogue inhibit Rtt109 catalysis 
(Tang et al., 2008). More recently, a small molecule inhibitor of p300 was identified 
through a virtual ligand screen, and this also has no effect on Rtt109 (Bowers et al., 
2010). Curcumin (from tumeric), anarcadic acid (from cashew nut oil) and garcinol 
(from the Garcinia indica fruit) are natural compounds that have inhibitory effects 
towards all three HAT family members, including p300, Gcn5, and Tip60 
(Balasubramanyam et al., 2003; Balasubramanyam et al., 2004; Cui et al., 2007; 
Mantelingu et al., 2007; Marcu et al., 2006; Sun et al., 2006). However, their multiple 
targets make them unsuitable as specific inhibitors. In short, none of the known HAT 
inhibitors are promising lead compounds for chemical manipulation to develop a 
specific Rtt109 inhibitor. 
 Compounds that inhibit Rtt109 are predicted to cause sensitivity to DNA 
damage in yeast cells. An analogous situation exists for the human MYST-family 
HAT, TIP60. TIP60 is recruited to sites of DNA damage and acetylates multiple 
histone residues during DNA repair (Sun et al., 2005). Notably, inhibition of TIP60 
by anacardic acid sensitizes human cells to DNA damaging agents (Sun et al., 2006). 
Since Rtt109 promotes C. albicans pathogenesis (Lopes da Rosa et al., 2010), a 
chemical inhibitor of the enzyme is expected re-capitulate this phenotype and make 
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for a novel anti-fungal drug candidate. Examination of protein databases reveals 
homologs of Rtt109 only among other fungal species. The close homology of the 
fungal Rtt109 enzymes, including residues essential for catalytic activity (Han et al., 
2007a; Tsubota et al., 2007), suggest that inhibitory compounds are likely to be 
effective against Rtt109 proteins from multiple fungal species. Furthermore, the 
dissimilarity between Rtt109 and enzymes of other HAT families indicate that a 
specific inhibitor will have minimal activity and toxicity towards mammalian 
proteins. 
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CHAPTER 2
Histone acetyltransferase Rtt109 is required for Candida albicans
pathogenesis
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ABSTRACT
Candida albicans is a ubiquitous opportunistic pathogen that is the mostprevalent cause of hospital-­‐acquired fungal infections. In mammalian hosts, C.
albicans is engulfed by phagocytes that attack the pathogen with DNA-­‐damagingreactive oxygen species (ROS). Acetylation of histone H3 lysine 56 (H3K56) bythe fungal-­‐specific histone acetyltransferase Rtt109 is important for yeast modelorganisms to survive DNA damage and maintain genome integrity. To assess theimportance of Rtt109 for C. albicans pathogenicity, we deleted the predictedhomologue of Rtt109 in the clinical C. albicans isolate, SC5314. C. albicans rtt109 -­
/-­ mutant cells lack acetylated H3K56 (H3K56ac) and are hypersensitive togenotoxic agents. Additionally, rtt109 -­/-­ mutant cells constitutively displayincreased H2A S129 phosphorylation and elevated DNA repair gene expression,consistent with endogenous DNA damage. Importantly, C. albicans rtt109 -­/-­‐ cellsare significantly less pathogenic in mice and more susceptible to killing bymacrophages in vitro than are wild-­‐type cells. Via pharmacological inhibition ofthe host NADPH oxidase enzyme, we show that the increased sensitivity of
rtt109 -­/-­ cells to macrophages depends on the host’s ability to generate ROS,providing a mechanistic link between the drug sensitivity, gene expression andpathogenesis phenotypes. We conclude that Rtt109 is particularly important forfungal pathogenicity, suggesting a novel target for therapeutic antifungalcompounds.
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INTRODUCTIONThe basic repeating unit of eukaryotic chromatin, termed the nucleosome,is composed of 146 base pairs of DNA wrapped around an octamer of corehistone proteins, containing two copies each of H2A, H2B, H3 and H4 (Luger etal., 1997). Post-­‐translational modifications (PTM) of histone molecules promotevarious chromatin functions including replication, repair, transcription, andsilencing (Groth et al., 2007; Li et al., 2007; Millar and Grunstein, 2006). In theyeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe, newlysynthesized histone H3 molecules are abundantly acetylated on lysine 56(Kaplan et al., 2008; Masumoto et al., 2005; Xhemalce et al., 2007). In S.
cerevisiae, H3K56 acetylation is required for replication fork stability (Duro etal., 2008; Tsubota et al., 2007), reassembly of chromatin after DNA damagerepair, and histone association with chromatin assembly proteins (Chen andTyler, 2008; Erkmann and Kaufman, 2009; Kim and Haber, 2009; Li et al., 2008).A fungal-­‐specific histone acetyl-­‐transferase (HAT) enzyme, termed Rtt109 andits stimulatory histone chaperone co-­‐factor, Asf1, are required for H3K56acetylation (Driscoll et al., 2007; Han et al., 2007a; Recht et al., 2006; Tsubota etal., 2007). S. cerevisiaemutants lacking Rtt109 or Asf1 display delayed cell cycleprogression (Driscoll et al., 2007), spontaneous DNA damage (Fillingham et al.,2008; Masumoto et al., 2005; Prado et al., 2004), unstable replication forks, andare extremely sensitive to DNA damaging agents (Tsubota et al., 2007). Inaccordance, point mutation of H3 lysine 56 to arginine, which cannot be
32
acetylated and mimics a positively charged, unacetylated lysine, results insimilar phenotypes (Masumoto et al., 2005; Recht et al., 2006). Therefore,acetylation of H3K56 is a particularly important PTM for fungal growth.
C. albicans is an opportunistic pathogen that poses a considerable publichealth problem, with an estimated 40%mortality rate for systemic candidiasis(Gudlaugsson et al., 2003; Pfaller and Diekema, 2007). Antifungal drugresistance is a major clinical problem, and few drugs are available to battle
Candida infections (Cannon et al., 2007). H3K56 acetylation appears to be muchless abundant in mammals than in yeasts (Garcia et al., 2007; Xie et al., 2009;Zhang et al., 2003) and close homologues of Rtt109 are not detected outside ofthe fungal kingdom (Bazan, 2008; Tang et al., 2008). Therefore, we hypothesizedthat Rtt109 might provide a new target for antifungal therapeutics, and webegan to investigate the importance of H3K56 acetylation in fungalpathogenicity.During the course of a systemic infection, C. albicans cells are engulfed byhost phagocytes, where they are exposed to ROS (Vázquez-­‐Torres and Balish,1997). ROS contribute to efficient killing of C. albicans both in cultured cells andwhole organisms (Aratani et al., 2002b; Donini et al., 2007; Stevenhagen and vanFurth, 1993; Thompson andWilton, 1992). ROS directly damage DNA, as well ascellular proteins and lipids (Haghnazari and Heyer, 2004; Salmon et al., 2004).Upon incubation with macrophages, C. albicans DNA repair genes aretranscriptionally induced (Lorenz et al., 2004), suggesting that DNA damage
33
indeed occurs in the phagosome and that hypersensitivity to genotoxic stresswould be disadvantageous to the pathogen. Because H3K56 acetylation isessential for yeast to survive genotoxic stress, we investigated the role of Rtt109in C. albicans pathogenicity.
RESULTS
C. albicans ORF19.7491 encodes the Rtt109 functional homologueWe identified C. albicans ORF19.7491 as the likely Rtt109 functionalhomologue through primary sequence homology. Also, the recent high-­‐resolution structures of S. cerevisiae Rtt109 (Stavropoulos et al., 2008; Tang etal., 2008) highlight several catalytic domains that are well-­‐conserved betweenthe two species (Fig. 2.S1A). C. albicans is an obligate diploid that lacks a classicalsexual cycle, so two sequential rounds of gene deletion are required to generatehomozygous mutants. For this, we employed the Candida-­‐adapted Flp/FRTsequence-­‐specific recombination system to replace the target locus (Reuss et al.,2004). This system leaves behind a single 34 bp FRT site after excision (Fig.2.S1b). All genotypes were confirmed using PCR (Fig. 2.S1C, Table 2.S3).Immunoblot analysis demonstrated that H3K56ac was lost in homozygous
rtt109 -­/-­ mutant cells, whereas in RTT109 +/-­‐ heterozygous cells H3K56ac wasmaintained (Fig. 2.1A). To verify that the phenotypes observed resulted from theintended deletion, we generated a “complemented” strain, RTT109 FH/-­‐, by re-­‐introducing a 2xFlag-­‐6xHIS-­‐tagged RTT109 gene at the endogenous locus of the
34
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homozygous mutant (Fig. 2.S1B and 2.S1C). As anticipated, H3K56ac wasrestored in the complemented RTT109 FH/-­ strain (Fig. 2.1A). We conclude that C.
albicans ORF19.7491 encodes a functional Rtt109 homologue.
C. albicans rtt109 -­/-­ cells are sensitive to genotoxic agents
C. albicans can grow in multiple morphological states. Individual cellsappear as budded or filamentous cells (Sudbery et al., 2004). The ability toswitch among these morphologies is required for C. albicans pathogenicity(Laprade et al., 2002; Lo et al., 1997), suggesting that multiple morphologiescontribute to host infection. Filamentous growth can be triggered by variousstimuli including oxidative stress (Nasution et al., 2008), activation of the DNAdamage and replication checkpoints due to exogenous or endogenous DNAdamage (Andaluz et al., 2006; Shi et al., 2007), or by cell cycle delays resultingfrom perturbed microtubule dynamics or spindle checkpoint activation (Finleyand Berman, 2005; Finley et al., 2008), (reviewed in (Berman, 2006)).We therefore examined single cell and colony morphology of rtt109 -­/-­mutants. Unlike the smooth wild-­‐type and RTT109 FH/-­‐ colonies, rtt109 -­/-­ colonieswere wrinkled, suggesting a heterogeneous population (Fig. 2.1B). By examiningindividual cells, we observed that a large proportion of rtt109 -­/-­ cells werefilamentous (Fig. 2.1B). In contrast, wild-­‐type and RTT109 FH/-­‐ C. albicanspopulations were homogeneous budded cells. In S. cerevisiae, inability toacetylate H3K56 leads to spontaneous DNA damage (Driscoll et al., 2007; Han et
36
Figure 2. 2. Candida albicans rtt109 -/- cells are hypersensitive to genotoxic agents 
but not all antifungal drugs. (a) Five-fold serial dilutions of the indicated strains on 
rich media (YPD) supplemented with campthotecin (CPT), methyl methane sulfonate 
(MMS) and hydrogen peroxide (H2O2). Plates were photographed after 2 days at 30°. (b- 
e) Percent growth inhibition in the presence of indicated drugs in RPMI 1640 was 
measured after 16-18 hrs at 35° by optical density 600 nm. Results are mean of 
triplicates ± s. d. 
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al., 2007a) and constitutive checkpoint activation (Driscoll et al., 2007), which asa result delay G2-­‐M progression (Driscoll et al., 2007). We therefore suspectedthat constitutive DNA damage causes the aberrant morphology of C. albicans
rtt109-­/-­ mutants. We examined the mutant cells for phosphorylation of histoneH2A serine 129 (γH2A), a well-­‐conserved modification that is triggered by DNAdouble strand breaks (Redon et al., 2003). Low levels of γH2A are constitutivelypresent in S. cerevisiae asf1Δ and rtt109Δ strains (Fillingham et al., 2008; Pradoet al., 2004). Indeed, C. albicans rtt109 -­/-­ mutants displayed elevated amounts of
γH2A in the absence of exogenous DNA damaging agents (Fig. 2.1C). As expectedfor cells that undergo constitutive checkpoint activation, C. albicans rtt109 -­/-­mutants had a moderately longer doubling time (Fig. 2.1D). We conclude thatloss of Rtt109 stimulates C. albicans filamentation, likely via an increase inspontaneous DNA damage and loss of genomic stability. Accordingly, C. albicans
rtt109 -­/-­ cells were hypersensitive to the genotoxic agents campthotecin (CPT), atopoisomerase poison, and methyl methane sulfonate (MMS), a DNA alkylatingagent (Fig. 2.2A). C. albicans rtt109 -­‐/-­‐mutants were also hypersensitive tohydrogen peroxide (H2O2), one of the ROS employed by phagocytes to killengulfed C. albicans (Vázquez-­‐Torres and Balish, 1997) (Fig. 2.2A and 2.2B).
Flucytosine (5-­‐fluorocytosine; 5FC) is a clinically approved antifungalagent used to treat systemic candidiasis (Pfaller and Diekema, 2007). As anucleotide analogue, it impedes DNA synthesis (Polak and Scholer, 1975),
39
suggesting that mutants defective for replication fork stability may be moresensitive to this compound. We therefore tested sensitivity to 5FC and observedthat the minimal inhibitory concentration was diminished for rtt109 -­/-­ mutants(Fig. 2.2C). These data suggest that impairing Rtt109 could improve theeffectiveness of 5FC in a chemotherapeutic setting. Notably, rtt109-­/-­ mutantswere not hypersensitive to the antifungal drugs fluconazole or amphotericin B(Fig. 2.2D and 2.2E), both of which affect cell membrane synthesis (Cannon et al.,2007). These data reinforce the notion that pharmacological sensitivities of the
rtt109 -­/-­ mutant cells are specifically related to genome stability.
C. albicans pathogenicity is diminished in the absence of Rtt109Murine systemic candidiasis is a well-­‐established model to studypathogenesis by C. albicans (de Repentigny, 2004; Spellberg et al., 2005). Weinfected BALB/cByJ mice with 1.0 x 105 wild-­‐type, rtt109 -­‐/-­‐ or RTT109 FH/-­‐ cellsby tail vein injection. We monitored morbidity and mortality twice daily andobserved that the rtt109 -­/-­ cells were significantly deficient in causing fatalpathogenesis compared to wild-­‐type (p-­‐value 0.0435) and RTT109 FH/-­complemented (p-­‐value 0.0377) strains (Fig. 2.3A). The difference in lethalitycaused by rtt109 -­‐/-­‐ and wild-­‐type strains was even more significant (p < 0.001)when mice were infected with 1.5 x 105 cells (Fig. 2.3B). To determine whetherthese phenotypes correlated with proliferation of the pathogen in the animal, weretrieved single kidneys from infected animals and assessed fungal burden at 3
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and 20 days post infection by serial dilution of tissue homogenates on YPD agar(Fig. 2.3C and 2.3D). We observed that mice infected with wild-­‐type orcomplemented C. albicans strains had comparable renal fungal loads. In contrast,mice infected with the rtt109 -­/-­ mutant carried negligible amounts of yeast. Weconclude that C. albicans requires Rtt109 for efficient pathogenesis in mice.
C. albicans rtt109 -­/-­ cells are more susceptible to ROS-­mediated killing by
macrophagesMacrophages play an important role in controlling C. albicans infections(Vázquez-­‐Torres and Balish, 1997). To determine whether macrophage-­‐mediated growth inhibition could contribute to the observed decrease in C.
albicans rtt109 -­/-­ pathogenicity, we quantified yeast cell survival after exposureto a mouse-­‐derived macrophage-­‐like cell line, ZBM2. After a 15-­‐16 hour co-­‐incubation at a ratio of 1 fungal cell per 15 ZBM2 cells, proliferation of rtt109 -­/-­cells was significantly more inhibited by macrophages than were wild-­‐type C.
albicans cells (p-­‐value 0.025; Fig. 2.3E). We repeated these experiments in thepresence of an NADPH-­‐oxidase inhibitor (DPI; diphenyleneiodium chloride) toinhibit generation of ROS by the macrophages (Hancock and Jones, 1987).Previous work has shown that inhibition of NADPH-­‐oxidase in phagocytes byDPI decreases the fungicidal activity against C. albicans (Donini et al., 2007;Stevenhagen and van Furth, 1993). We determined that in the presence of DPI,survival of macrophage killing by the rtt109 -­/-­ cells was increased to the same
42
level observed for wild-­‐type cells (Fig. 2.3E). We conclude that without Rtt109, C.
albicans is more susceptible to killing by mammalian host macrophages becauseof the ROS deposited into phagosomes of macrophages.
rtt109 -­/-­ cells display an altered profile of metabolic gene expression and
constitutively induce DNA repair genesTo gain further insight into the altered phenotypes of the rtt109 -­/-­mutantcells, we performed microarray analysis of gene expression. We first comparedlogarithmically growing wild–type and rtt109 -­/-­mutant cells in rich (YPD) media,focusing on genes that displayed a greater than two-­‐fold change with a p-­‐value<0.01 (see Materials and Methods). Among this group was a large number ofgenes involved in the response to DNA damage, almost all of which displayedelevated expression in the rtt109 -­/-­mutant cells (Table 2.S4A). In contrast, manyof the genes most highly down-­‐regulated in the mutant cells were related tocarbohydrate metabolism (Table 2.S4B), To extend these observations, GO-­‐termanalysis was performed to quantify the enrichment of genes associated withbiological processes. Many of the enriched GO-­‐terms significantly overlapped,such that all of the enriched biological process terms can be generallycategorized as being involved in carbohydrate metabolism, DNA damage andrepair, or mitochondrial function (Fig. 2.4). Together, the transcription datasuggests two major trends: complex miss-­‐regulation of energy metabolism inmutant cells, and constitutive DNA damage signaling.
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To investigate the sensitivity of rtt109 -­/-­ cells to ROS, we also analyzedgene expression changes in cells exposed to 0.4 mM hydrogen peroxide for 10minutes, a treatment that has previously been shown to induce a DNA damageresponse (Enjalbert et al., 2003; Enjalbert et al., 2006). Under these conditions,we observed that there were many more genes with elevated rather thanreduced RNA levels in the rtt109 -­/-­mutant cells (Table 2.S5). We note that thebroad group of DNA repair genes that was elevated in the YPD-­‐grown mutantcells was not observed in the comparison of strains grown in the presence ofH2O2, likely because both strains in this experiment are responding to H2O2-­‐mediated DNA damage. Notably, genes that specifically respond to oxidativestress (e.g. superoxide dismutases encoded by SOD3, SOD4, and SOD5) weremore highly induced in mutant cells, leading to significant enrichment ofmultiple GO terms related to oxidative stress (Fig. 2.5). Therefore, rtt109 -­‐/-­‐mutant cells appear able to sense and mount a vigorous transcriptional responseto oxidative stress, but appear unable to survive in phagocytes or mice.Additionally, in the presence of H2O2 the mutant cells up-­‐regulate genesrelated to cell wall synthesis (Fig. 2.5). In contrast, enriched GO terms related tocell adhesion, interaction and biofilm formation mostly included genes down-­‐regulated in the mutant cells. It remains a possibility that some of these complexincreases and decreases could contribute to the loss of pathogenicity in rtt109 -­‐/-­‐mutant cells (Fig. 2.3). However, given the pharmacological data showing that
rtt109 -­‐/-­‐mutant cells are sensitive to killing by macrophages because of host-­‐
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generated reactive oxygen species (Fig. 2.3E), we favor the idea that increasedsensitivity to oxidative stress is the major cause of this phenotype.Several genes that displayed transcriptional differences by microarray werevalidated through RT-­‐PCR experiments. These genes included RTT109, RAD51,
IFE2, HHO1, HTZ1, SOD5, DDR48, ALS1 and PCK1 (Fig. 2.S2). Similar alterations inRNA levels were detected by the microarrays and by RT-­‐PCR for both theunperturbed and H2O2-­‐stressed samples. We conclude that we have accuratelydetected gene expression changes in our experiments.
DISCUSSIONWe have identified the C. albicans Rtt109 acetyltransferase that modifiesH3K56 (Fig. 2.1A). Importantly, we show that Rtt109 is required for efficientpathogenesis in mice, and our in vitro data suggest that increased susceptibilityto macrophages makes rtt109 -­/-­ mutant cells less pathogenic (Fig. 2.3). Ourresults are consistent with previous data suggesting that efficient DNA repair isrequired for pathogenesis. For example, C. albicans rad52 -­/-­ mutants are unableto perform homologous recombination as a mode of DNA repair, and are lesspathogenic in mice (Chauhan et al., 2005). Our data specifically emphasize theimportance of reactive oxygen species generated in mammalian hostphagosomes for killing C. albicans. Previously,mice that lack the NADPH oxidaseenzyme responsible for generating ROS in phagocytes were shown to experiencegreater rates of mortality during systemic C. albicans infections (Aratani et al.,
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2002b). Here, we demonstrate that the increased sensitivity of rtt109 -­/-­ cells tomacrophages requires NADPH oxidase function (Fig. 2.3E). We conclude thatH3K56 acetylation by Rtt109 is a new example of how the ability to withstandgenotoxic agents is important for C. albicans pathogenesis.Genome-­‐wide expression profiling of C. albicans in the presence of severaltypes of host cells has been performed (reviewed in (Brown et al., 2007;Kumamoto, 2008)). These studies indicate that alterations in metabolism andstress response genes often occur upon interaction with host cells. For example,after phagocytosis, glycolytic genes are down-­‐regulated and fatty acid oxidationand glyoxylate cycle genes are up-­‐regulated (Fradin et al., 2005; Lorenz et al.,2004)}. Phagocytic cells are particularly important for this response, becauseerythrocytes and mononuclear cells have little effect on C. albicans geneexpression, but an enriched population of polymorphonuclear cells (mostlyneutrophils and eosinophils) down regulates glycolytic genes, including HXK2(hexokinase II) and PGI1 (phosphoglucoisomerase), as well as glyoxylate cyclegenes, includingMLS1 (malate synthase). Neutrophils also induce an oxidativestress response, including activation of SOD5, a cell surface-­‐associatedsuperoxide dismutase (Fradin et al., 2005). Similar trends are also seen in the
rtt109 -­/-­ mutant cells. Together, the coordinated down-­‐regulation of glycolysisand up-­‐regulation of the glyoxylate cycle in mutant cells grown in rich mediacontaining a large amount of glucose suggests that rtt109 -­/-­ mutant cells are lesswell able to utilize sugars for metabolism, and rely more on glyoxylate cycle
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enzymes to convert fats to carbohydrates. As noted above, there are alsocomplex alterations of gene expression related to mitochondrial andperoxisomal metabolism and cell wall synthesis. Howmuch the metabolicalterations in rtt109 -­/-­ mutant cells contribute to the pathogenesis phenotypehas yet to be resolved. Some of these alterations may be via indirect changes tochromatin, because we also observed that two histone isoform genes, HHO1 and
HTZ1, display reduced RNA levels in the mutant cells in YPD (Fig. 2.S2; Table2.S4). However, because rtt109 -­/-­ cells became as resistant to macrophages aswere wild-­‐type cells upon inhibition of host NADPH oxidase (Fig. 2.3E), we favorthe hypothesis that the sensitivity of rtt109 -­/-­ cells to exogenous DNA damagingagents (Fig. 2.2), reflected by their constitutive response to endogenous damage(Fig. 2.1C, 2.4 and Table 2.S4), largely explains why Rtt109 is important forpathogenesis.Recent analyses of telomere-­‐proximal gene silencing in the budding yeast
S. cerevisiae has suggested that elevated levels of H3K56 acetylation antagonizesepigenetic silencing of telomere-­‐proximal genes (Xu et al., 2007a; Yang et al.,2008), although deletion of RTT109 has little effect on silencing (Yang et al.,2008). To determine whether loss of Rtt109 in C. albicansmight cause position-­‐dependent alteration of gene expression at telomeres, we paid particularattention to telomere-­‐proximal genes in these analyses (Table 2.S6). Genes withelevated and reduced transcript levels in rtt109 -­/-­ cells were observed, and theredid not appear to be any smooth trends that originate from the chromosome
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ends in these data sets; this is especially evident at the chrR right telomere.Moreover, many of the altered genes near telomeres can be explained by trendssuggested from the GO term analyses. For example, there are several stress-­‐,damage-­‐ and hyphal-­‐induced genes that display elevated expression in themutant cells (e.g. XYL2, DFM1, orf19.7531, SOD3, and to a lesser extent, RAD3 and
NAG1). Although it remains an open possibility that H3K56ac may play a role inposition-­‐dependent gene expression at some of the altered loci we havedetected, our data suggest that the most salient changes in gene expression arerelated to DNA damage induction and alterations in cellular metabolism ratherthan chromosomal position.Because Rtt109 is well-­‐conserved among fungal species (Fig. 2.S1), wepropose that Rtt109 is a strong candidate target for therapeutic interventionagainst fungal pathogens, not limited to C. albicans. Although mammalianp300/CBP HAT enzymes are distant Rtt109 homologues, many catalyticallyimportant residues in p300/CBP are distinct from those in Rtt109 (Tang et al.,2008). In fact, compounds that inhibit p300/CBP have no effect on Rtt109 (Tanget al., 2008), indicating that the potential for discovering specific inhibitors offungal Rtt109 enzymes is promising.
Experimental Procedures:
Yeast culture. Strains were constructed as described in the SupplementaryMaterial. C. albicans strains were grown in Yeast Extract Peptone (YEP; 0.1%
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yeast extract, 0.2% peptone) supplemented with 2% dextrose (YPD; rich media)or 2%maltose. When indicated, yeast cells were cultured in Yeast nitrogen base(YNB; 0.67% yeast nitrogen base, 0.77% complete synthetic media, and 2%dextrose) or Yeast Carbon Base (YCB; 0.234% yeast carbon base, 0.2% yeastextract, 0.4% BSA, pH 4) media at 30°. Where mentioned, media weresupplemented with 200 µg ml -­‐1 nourseothricin (ClonNat, Werner BioAgents) or10 µg ml -­‐1 mycophenolic acid (Sigma-­‐Aldrich, Inc.).
Immunobloting. Alkaline whole cell lysates (Fig. 2.1A) were obtained aspreviously described (Kushnirov, 2000). Samples were separated on 17%polyacrylamide SDS gels, transferred onto polyvinylidene fluoride and probedwith rabbit anti-­‐H3K56ac (1:2000, Abcam), or rabbit anti-­‐H3 (1:1000, Abcam).Whole cell lysates (Fig. 2.1C) were obtained from 50 ml log-­‐phase cultures inYPD and washed twice in whole cell extract buffer (20 mM Hepes pH 7.0, 350mM NaCl, 10% glycerol, 0.1% tween-­‐20) in the presence of 1 µg ml -­‐1 aprotinin,0.16 mg ml -­‐1 benzamidine, 0.5 µg ml -­‐1 leupeptin, 0.7 µg ml -­‐1 pepstatin and 0.17mg ml -­‐1 phenylmethylsulphonyl fluoride (PMSF). Pellets were resuspended with1 ml whole extract buffer. An equal volume of glass beads was added and cellswere agitated on a mini bead-­‐beater at 4°C, for four 1-­‐minute pulses. Glass beadswere then separated from the lysate by centrifugation at 2,500 x g, at 4°C for 5minutes. Next, insoluble material was pelleted by centrifugation at 18,000 x g, at4°C for 10 minutes. The soluble supernatant was recovered and protein
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concentrations were determined by Bradford assay. 15 μg of protein was usedfor immunoblotting with rabbit anti-­‐H2A-­‐phosphorylated S129 (1:4000, Abcam)or rabbit anti-­‐ H2A (1:3000, Abcam) antibodies.
Antifungal sensitivity assay. To determine minimal inhibitory concentrationsof amphotericin B (AMB; Fluka, Sigma-­‐Aldrich), fluconazole (FCZ; Sigma-­‐Aldrich)and 5-­‐fluorocytosine (5FC; Sigma-­‐Aldrich), we followed the EUCAST brothdilution method as previously described (Cuenca-­‐Estrella et al., 2003). Briefly,AMB and FCZ were reconstituted in DMSO, and 5FC in water. Two-­‐fold serialdilutions of antifungal agents (or vehicle) were prepared in RPMI1640, 2%dextrose, 165 mMMOPS, pH 7.0, in triplicate in a microtiter plate. 2.5 x 104 log-­‐phase yeast cells were subsequently added to each well and incubated for 16-­‐18hours at 35°. Growth was determined by optical density at wavelength 600 nmand compared to cells exposed to vehicle alone.
Murine Candidiasis. BALB/cByJ female mice (Jackson Lab), 6-­‐8 weeks old, wereinjected in the tail vein with log-­‐phase C. albicans cells suspended in 400 µl PBS.Moribund mice were sacrificed by cervical dislocation. To assess fungal load, theleft kidney was sterilely dissected and homogenized in 0.02% Triton-­‐X 100. Five-­‐fold serial dilutions of the homogenized tissue were plated on YPD agar for 24hours at 30° and photographed.
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All animals were maintained under specific pathogen-­‐free conditions inthe animal facilities at UMass Medical School (UMMS). All experiments involvinglive animals were carried out in accordance with the guidelines set forth by theUMMS Department of Animal Medicine and the Animal Use protocol approved bythe Institutional Animal Care and Use Committee (IACUC).
Macrophage growth inhibition assay. A macrophage cell line, termed ZBM2,was derived from C57BL/6J bone marrow and immortalized by retroviraltransduction of SV40 large T antigen. The cell line was maintained in DMEMsupplemented with 10% heat inactivated fetal bovine serum, 10% L-­‐929 cellconditioned media, 100 units ml -­‐1 penicillin and 100 µg ml -­‐1 streptomycin.Macrophage cells were plated at a density of 2 x 106 per 35 mm2 dish andallowed to adhere for 5 hours. Log-­‐ phase C. albicans grown in YEP were washedin DMEMmedia, plated to a 1:15 macrophage ratio in a final volume of 2 mL andincubated at 37° in 5% CO2 overnight. Samples were collected into 14 ml 0.02%Triton-­‐X100 (v/v) in water to osmotically lyse macrophages. Dilutions of eachsample were plated onto YPD and placed at 37° to assess colony-­‐forming units(CFU). Percent growth inhibition was calculated relative to yeast culturesincubated in parallel without macrophages. Experiments withdiphenyleneiodium chloride (DPI) were performed similarly with the inclusionof 0.75 μM DPI from a 31.8 mM stock solution in DMSO. Conditions without DPI
55
included the same final concentration of 0.002% DMSO. All experiments wererepeated at least four separate times.
Statistics. The survival data for the positive control and the experimentalgroups (Fig. 2.3A -­‐B) were compared using the Mantel-­‐Cox method. Statisticalanalysis of macrophage growth inhibition assay (Fig. 2.3E) was determined bypaired two-­‐tailed Student t-­‐test. The software used was GraphPad Prism.
RNA extraction andmicroarray hybridizationFour independent pairs of biological replicate samples were analyzed tocompare RNA levels in wild-­‐type and rtt109 -­/-­ cells. Two experiments wereperformed: first, in unperturbed cells grown in YPD and second, in cells exposedto H2O2. To account for dye effects, two of the four samples for each experimentwere analyzed using Cy3 labeling of the wild-­‐type sample and Cy5 labeling of themutant sample; the dyes were swapped for the other two biological replicates.In the first experiment, wild-­‐type and rtt109 -­/-­ cultures were grown at30°C in 50 ml YPD to a matching O.D. 600 nm for each of the four biologicalreplicates, with the final O.D. 600 nm ranging from 0.6-­‐0.9 for the differentexperiments. Pellets were flash frozen with liquid nitrogen and stored at -­‐80°Cuntil further processing. RNA was purified by acid-­‐phenol extraction followed byethanol, ammonium acetate precipitation as previously described (Sexton et al.,2007). DNA oligonucleotide C. albicansmicroarray slides were purchased from
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The Genome Center at Washington University(http://genome.wustl.edu/services/microarray/candida_albicans). 10 μg RNAwas labeled by reverse transcription using the 3DNA Array 350 system(Genisphere) and hybridization and washing were performed per themanufacturer’s instructions. Scanning was performed immediately afterwashing using GenePix software at a PTM ranging from 490-­‐630 (Cy3; 532nm)and 650-­‐960 (Cy5; 635nm).In the second experiment, RNA was analyzed from H2O2-­‐exposed cells. Inthis case, the final O.D. 600nm ranged from 0.5-­‐ 0.9 before exposure to 0.4 mMH2O2 in YPD for 10 minutes at 30°C. The cells were immediately centrifuged intoa pellet and flash frozen with liquid nitrogen for storage. RNA was then preparedand analyzed as above.
Bioinformatic analysis of RNA expressionLimma package (limma_2.18.0, (Smyth, 2004)) from Bioconductor was used forpreprocessing and model fitting. A linear model was fit to the background-­‐corrected, loess-­‐normalized and log-­‐transformed expression data. The dye effectand mutant effect were tested as explanatory variables to determine whetherthe expression level of each gene differed between mutant and wild typesamples, after the dye effect was removed statistically. Three features for eachgene were printed on the array, resulting in three estimated log-­‐fold changes foreach gene. Genes with at least one feature having a p-­‐value < 0.01 for mutant
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effect and a fold change ≥2 were considered potentially differentially expressedin mutant and were included for subsequent Gene Ontology (GO) enrichmenttest. The gene and GO term association list was downloaded fromhttp://www.candidagenome.org (version 1.633 and taxon: 5476) withduplicates removed. All the ancestor GO terms were added to the association listusing GO.db package (GO.db_2.2.11) from Bioconductor. GO enrichment analysiswas performed using the hypergeometric test in R (V 2.9.0). GO terms with atleast ten associated genes in the genome and a p-­‐value adjusted using B-­‐Hmethod (Benjamini and Hochberg, 1995) < 0.01 were considered significantlyenriched.
Acknowledgements. We thank Åshild Vik and Joachim Morschauser for strainsand plasmids. This work was supported by NIH R01 GM55712 (PDK), NIH F31 AI078726 (JLS) and NIH R01 AI060991 (VB). JLS and PDK conceived theexperiments, analyzed the data and wrote the paper, JLS performed theexperiments except for the mouse injections, which VB performed. VB alsohelped with experimental design and edited the manuscript. LJZ designed,analyzed the microarray experiments and edited the manuscript.
 
 
Supplementary Figure Legends
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Supplemental Figure 2.S1. Identification, deletion and restoration of
ORF19.7491, the Candida albicans homologue of the histone
acetyltransferase Rtt109. (a) Amino acid sequence alignment of C. albicans(C.a.) ORF19.7491 and S. cerevisiae (S.c.) Rtt109 performed with ClustalW2software. Residues shaded in dark gray are identical. Residues shaded in lightgray indicate charge and size conservation. Residues involved in catalysis areindicated by a rectangle (Han et al., 2007a; Stavropoulos et al., 2008; Tang et al.,2008; Tsubota et al., 2007). (b) Diagram of altered alleles at the C. albicans
RTT109 locus. (c) PCR confirmation of the indicated strains. (Oligonucleotidesused: X = OPK1110, Y = OPK1111, Z = OPK1112. See Table S3).
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Supplemental Figure 2.S2. RT-­PCR validation of microarray results. (a-­c).
Cells grown in YPD. (a) RT-­‐PCR detection of 18S rRNA (RDN18) in an RNApreparation that had been used for microarray analysis. RTT109was alsoassayed in these multiplex reactions as an internal control for strain identity.PCR reactions were also performed with cDNA samples made in mock reactionsomitting reverse transcriptase (“no RTase”). Using the same cDNA samplesanalyzed in panel (a), we also assayed (b) RAD51 (microarray Log2 Fold Change=1.51), a transcript more abundant in rtt109 -­/-­ cells and (c) IFE2 (Log2FC= -­‐2.73),
HHO1 (Log2FC= -­‐1.54), and HTZ1 (Log2FC= -­‐1.71), which are less abundant in
rtt109 -­/-­ cells. PCR products were loaded on 8% native gels in two-­‐folddecreasing volumes. Signals were quantified by densitometry using LabWorkssoftware. Each band was quantified with the values presented normalized to thesignal obtained from the least-­‐diluted sample from wild-­‐type cells. (d-­f) Cellsexposed to hydrogen peroxide. RNA samples from cells exposed to hydrogenperoxide were prepared and analyzed as described above. (d) Multiplex PCR for18S rRNA (RDN18) and RTT109. Detection of transcripts (e) elevated SOD5(Log2FC= 3.30), DDR48 (Log2FC= 2.14), PCK1 (Log2FC= 1.76) and (f) reduced
ALS1 (Log2FC= -­‐1.58) in rtt109 -­/-­ cells.
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Supplemental Table 2.S3: Primers and C. albicans strains used in this study
(a) DNA primersOPK1110 (X) ccttgtttaggagtgaatggOPK1111 (Y) tcaacagtaatgtctgtctaOPK1112 (Z) aaacaacaaacatttttgggRDN18 (f) cacgacggagtttcacaagaRDN18 (r) cgatggaagtttgaggcaatRTT109 (f) ctaatgattcctggggcagaRTT109 (r) ctgtaccgccaaaccatcttRAD51 (f) ggtgaattgagtgccagacaRAD51 (r) taatgaccacggcaataccaIFE2 (f) tgaaccattggcagtgtcatIFE2 (r) actttgtgccctttcaatgcHHO1 (f) agaaagctgccaccaaaaagHHO1 (r) tggagcagctttggtttcttHTZ1 (f) gtgcatggaggaaaaggaaaHTZ1 (r) gagcaggattacaattcccgASL1 (f) cctgctggttatcgtccattALS1 (r) gacgactgccagcacaagtaSOD5 (f) ctccaaaggcagtccatcatSOD5 (r) gggcaatcctttcaaatcaaDDR48 (f) ggtttcggtaaagacgacgaDDR48 (r) cgtcattggaagagccaaaPCK1 (f) gttgccaccagtctccaaatPCK1 (r) tgcggagaatgtagcttgtg
(b) Strain genotypes
RTT109 +/+ (SC5314) Wild-­‐type
RTT109 FS/-­ (PKA8) rtt109D::FRT / rtt109D::FRT-­RTT109-­‐2xFlag-­‐6xHis, SAT1-­‐FRT This study
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RTT109 FS/-­, FLP (PKA11) rtt109D::FRT / rtt109D::FRT-­‐RTT109-­‐2xFlag-­‐6xHis-­‐SAT1-­‐FRT; pSAP2::eCaFLP-­‐MPAR This study
rtt109 -­/-­ (PKA13) rtt109D::FRT / rtt109D::FRT;pSAP2::eCaFLP-­‐MPAR This study
RTT109 FH/-­ (PKA15) rtt109D::FRT / rtt109D::RTT109-­‐2xFLAG-­‐6xHis, SAT1 This study
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Supplemental Table 2.S4. Genes with altered RNA levels in rtt109 -­/-­ comparedto wild-­‐type C. albicans cells during logarithmic growth in YPD media. Listedhere are the mean log2 fold changes in RNA levels (rtt109 -­/-­ /wild type)estimated from the four biological replicates, so (a) positive values indicategreater RNA levels in the mutant cells, and (b) negative values indicate lowerRNA levels in the mutant cells. These are all the genes we detected with anaverage fold-­‐change of log2 equal or greater than 1 with a p-­‐value < 0.01 in atleast 2 of the 3 array features. Open reading frames not yet characterized in C.
albicans, but identified as an orthologue of a Saccharomyces cerevisiae protein bythe Candida Genome Database are indicated with “Sc” preceding the gene name.
(a) Genes with greater RNA levels in the mutant cells 
Gene name and description
Mean Log2
fold
changeCTN1, mitochondrial carnitine acetyltransferase 2.81HSP12, heat shock protein 2.52BMT3 Beta-­‐Mannosyl transferase 2.23orf19.7306, conserved uncharacterized protein 2.10SPS4, sporulation-­‐specific protein 2.04SAP7, secreted aspartyl proteinase 7 2.00DNA2, DNA helicase involved in DNA replication 1.82PST1, Protoplast-­‐Secreted protein 1.79PHO89, Na+/Pi symporter 1.77CAT2, carnitine acetyltransferase 1.77orf19.2769, hyphal-­‐induced (ScPBI2, proteinase B inhibititor) 1.77
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orf19.7531, conserved uncharacterized protein 1.74FOX3, Putative peroxisomal 3-­‐oxoacyl CoA thiolase 1.73orf19.4795, hypothetical protein 1.72SOD4, Cu/Zn superoxide dismutase 1.71orf19.4171, conserved uncharacterized protein 1.70orf19.5141, hypothetical protein 1.69EST2, telomerase reverse transcriptase 1.69FLO5, putative cell wall protein 1.66MDR1, benomyl/methotrexate resistance protein 1.66LYS22, homocitrate synthase 1.66orf19.4070, hypothetical protein 1.59RAD16, nucleotide excision repair protein 1.59DIP53, dicarboxylic amino acid permease 1.56PSF1, DNA-­‐dependent DNA replication, GINS complex subunit 1.55ARO10, pyruvate decarboxylase 1.55RAD51, DNA repair protein; RecA homolog 1.51ARG1, argininosuccinate synthetase 1.47MPH1, RNA helicase involved in DNA repair 1.46RAD7, nucleotide excision repair protein 1.45orf19.5780, conserved uncharacterized membrane protein 1.45MLH1, DNA mismatch repair protein 1.44PRI1, p48 polypeptide of DNA primase 1.41TES1, acyl-­‐CoA thioesterase 1.41orf19.1449, uncharacterized ORF (ScDDI2/ ScDDI3, DNA damage inducible) 1.40CIS36, hypothetical protein weakly similar to C-­‐terminus of PIR3-­‐likeproteins 1.34orf19.3627, conserved uncharacterized protein 1.34MDH99, dehydrogenase 1.33PSA2, mannose-­‐1-­‐phosphate guanyltransferase 1.32orf19.251, stress-­‐induced (ScHSP31, Heat shock protein) 1.32UGA22, succinate-­‐semialdehyde dehydrogenase; involved in utilization of 1.31
67
GABA as a nitrogen sourceDCD1, deoxycytidylate deaminase 1.30IFD1, conserved aryl-­‐alcohol dehydrogenase 1.30BDE99, 1,4-­‐butanediol diacrylate esterase 1.26CVT9, oligomeric, coiled-­‐coil, peripheral membrane protein 1.26orf19.6083, hypothetical protein 1.26ATF1, alcohol acetyltransferase 1.26AMO2, copper-­‐containing amine oxidase 1.25orf19.6263, Predicted membrane transporter (ScMCH4, Mono carboxylatetransporter 1.24EAP1, Enhanced Adherence to Polystyrene; glycosylphosphatidylinositol-­‐anchored cell wall protein involved in adhesion to human epithelial cells 1.23CPA2, carbamoyl phosphate synthetase large subunit, arginine biosynthesis 1.23CHS8, chitin synthase 8 1.18orf19.346, alanine transaminase (ScALT1) 1.17GRP3, induced by osmotic stress 1.16RBK1, ribokinase 1.16PRC2, carboxypeptidase Y precursor 1.16orf19.4830, hypothetical protein 1.15RNH2, ribonuclease H 1.15orf19.6117, similar to ER protein 1.15ZMS1, homolofous to Zinc Finger Protein C2H2 1.14orf19.4634, N-­‐type ATP pyrophosphatase superfamily (ScNCS6) 1.14ABP2, unknown function, induced by alpha-­‐factor 1.13orf19.3292, conserved uncharacterized protein (ScMXR2, Methioninesulfoxide reductase) 1.12MEC1, cell cycle checkpoint protein 1.09ARA1, D-­‐arabinose dehydrogenase 1.08orf19.4749, hypothetical protein 1.07orf19.4316, Trimethyllysine dioxygenase, the first enzyme in the carnitinebiosynthesis pathway 1.05
68
MNN13, mannosyltransferase 1.03MEF2, mitochondrial elongation factor G-­‐ like protein 1.01
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(b) Genes with lower RNA levels in the mutant cells  
Gene name and description
Mean Log2
fold
changeSTM1, purine motif triplex-­‐binding protein; specific affinity for guanine-­‐richquadruplex nucleic acids -­‐4.08SCW10, soluble cell wall protein similar to mannoprotein MP65 -­‐3.69UCF1, Up-­‐regulated by CAMP in Filamentous -­‐2.75IFE2, Zn-­‐containing alcohol dehydrogenase -­‐2.73HXK2, hexokinase II -­‐2.68RHD3, conserved protein repressed in hyphal development -­‐2.44HXT6, hexose transporter -­‐2.26SAH1, S-­‐adenosyl-­‐L-­‐homocysteine hydrolase -­‐2.23COX12, cytochrome c oxidase subunit VIb -­‐2.16ZRT2, low affinity zinc transporter -­‐2.04CAM1, translation elongation factor eEF1 gamma, protein level decreased instationary phase cultures -­‐1.95orf19.1196, conserved uncharacterized protein with ser/thr kinase domain(ScPKH3, Pkb-­‐activating Kinase Homolog) -­‐1.88HTZ1, histone variant involved in chromatin and transcriptional control -­‐1.71orf19.4450.1, hypothetical protein identified by cDNA isolation -­‐1.67BUB3, cell cycle arrest protein -­‐1.61HHO1, histone H1 -­‐1.54PIR1, cell wall structural constituent with tandem repeats -­‐1.52orf19.5626, conserved uncharacterized protein -­‐1.48ADAEC, (ScAGA1, agglutinin subunit) -­‐1.47orf19.3448, hypothetical protein -­‐1.39orf19.5267, Putative cell wall protein -­‐1.38PCK1, phosphoenolpyruvate carboxykinase -­‐1.35MAE1, mitochondrial malate dehydrogenase -­‐1.33
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GPM2, phosphoglycerate mutase -­‐1.32RTT109, Regulator of Ty1 Transposition, Histone acetyltransferase critical forcell survival in the presence of DNA damage during S phase -­‐1.32FDH1, formate dehydrogenase -­‐1.29PCL7, cyclin like protein interacting with PHO85 -­‐1.27orf19.3713, dubious protein -­‐1.23SAM4, AdoMet-­‐homocysteine methyltransferase -­‐1.18AOX2, alternative oxidase -­‐1.18CDR4, ABC transporter -­‐1.16orf19.5136, conserved uncharacterized protein -­‐1.15NRG1, transcriptional repressor -­‐1.13FGR41, putative GPI-­‐anchored protein -­‐1.13MAD1, coiled-­‐coil protein involved in the spindle-­‐assembly checkpoint -­‐1.12orf19.3302, conserved uncharacterized protein, (ScPIG2, Putative type-­‐1protein phosphatase targeting subunit that tethers Glc7p type-­‐1 proteinphosphatase to Gsy2p glycogen synthase) -­‐1.09orf19.1653, hypothetical protein -­‐1.09orf19.951, hypothetical protein, transcription downregulated upon yeast-­‐hyphal switch -­‐1.06orf19.5282, hypothetical protein decreased expression in hyphae comparedto yeast-­‐form cells -­‐1.05orf19.2398, hypothetical protein -­‐1.04
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Supplemental table 2.S5: Genes with elevated expression in rtt109 -­/-­ comparedto wild-­‐type C. albicans cells during exposure to hydrogen peroxide. Criteria forinclusion of genes are as described for Table S4.
(a) Genes with greater RNA levels in the mutant cells
Gene name and description
MEAN
log2 fold
changeSOD5, copper-­‐zinc superoxide dismutase 3.304IFD1, conserved aryl-­‐alcohol dehydrogenase 3.252LDG8, uncharacterized protein, regulated by peroxide stress 2.770orf19.7306, protein of aldo-­‐keto reductase family 2.309SOD4, Cu/Zn superoxide dismutase 2.289PGA13, Putative GPI-­‐anchored protein 2.167DDR48, flocculent specific protein 2.136IFD6, aryl-­‐alcohol dehydrogenase 2.010orf19.1691, conserved uncharacterized protein 1.864MLS1, malate synthase 1.778PCK1, phosphoenolpyruvate carboxykinase 1.760orf19.2213, conserved uncharacterized protein 1.671PRN1, RNA pol II transcription cofactor 1.648orf19.5514, conserved uncharacterized protein 1.645orf19.2724, conserved uncharacterized protein 1.628PST1, 1,4-­‐benzoquinone reductase; brefeldin A resistance protein;Protoplast-­‐Secreted protein 1.623orf19.6484, hypothetical protein 1.606TCD4, sulfonate dioxygenase 1.549PSA2, mannose-­‐1-­‐phosphate guanyltransferase 1.537FRE2, ferric reductase 1.524
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IFD4, aryl-­‐alcohol dehydrogenase 1.499ARO10, pyruvate decarboxylase 1.485AHP1, alkyl hydroperoxide reductase 1.482PHR1, pH regulated GPI-­‐anchored membrane protein that is required formorphogenesis 1.453GST3, glutathione S-­‐ transferase 1.441orf19.2515, hypothetical protein 1.417orf19.3351, hypothetical protein 1.354ALD5, aldehyde dehydrogenase 1.348orf19.3902, hypothetical protein 1.332orf19.6117, uncharacterized ER protein 1.310MSN4, zinc finger transcription factor 1.285ECE1, secreted cell elongation protein 1.281VPS45, vacuolar protein sorting associated protein 1.270orf19.5686, hypothetical protein 1.260FTH1, iron permease 1.251MDH99, dehydrogenase 1.250CLN3, G1 cyclin 1.246orf19.2512, possibly spurious ORF 1.241YTA7, ATPase 1.222orf19.2202, uncharacterized ORF 1.212orf19.5141 hypothetical protein 1.207UGA22, succinate-­‐semialdehyde dehydrogenase; involved in utilization ofGABA as a nitrogen source 1.193orf19.4873, hypothetical protein 1.189RBR1, Glycosylphosphatidylinositol (GPI)-­‐anchored cell wall proteinrequired for filamentous growth at acidic pH 1.188PRN3, RNA pol II transcription cofactor 1.181orf19.6592, Predicted membrane transporter, member of the aromaticacid:proton symporter (AAHS) family 1.174SNQ2, ABC transporter 1.171
73
IQG1, RAS GTPase-­‐activating-­‐like 1.125orf19.3615, conserved uncharacterized protein 1.114ACS1, acetyl-­‐coenzyme A synthetase 1.112orf19.6311, hypothetical protein 1.105orf19.2769, hyphal-­‐induced (ScPBI2, proteinase B inhibititor) 1.103PRN4, RNA pol II transcription cofactor 1.081RNH2, ribonuclease H 1.075ZTA1, NADPH:quinone reductase; zeta-­‐crystallin 1.071orf19.5799, conserved uncharacterized protein 1.066EEP1, conserved hypothetical protein 1.065orf19.6315, hypothetical protein 1.062ALD6, mitochondrial aldehyde dehydrogenase 1.058SAP7, secreted aspartyl proteinase 7 1.052FAV2, uncharacterized, filament-­‐induced protein 1.023
(b) Genes with lower RNA levels in the mutant cells
Gene name and description
Mean Log2
fold
changeRTT109, Regulator of Ty1 Transposition, Histone acetyltransferase critical forcell survival in the presence of DNA damage during S phase -­‐3.375orf19.675, conserved uncharacterized protein, similar to cell wall proteins,induced in core stress response -­‐2.306ALS1, agglutinin like protein 1 -­‐1.582PRY2, homology to plant PR-­‐1 class of proteins -­‐1.261ALS4, agglutinin like protein 4 -­‐1.152FGR41, putative GPI-­‐anchored protein -­‐1.124
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Supplemental table 2.S6: telomere-­proximal genes. Open reading frameswithin at least 16kb of each telomere are listed, starting frommost telomere-­‐proximal at the top of the list for each telomere. The mean log2 fold changes inRNA levels (rtt109 -­/-­ /wild type) are indicated on the right. Values for geneswith greater expression in the mutant cells (positive log2 fold change values) >1.0 are indicated in green and bold. Genes with less expression in the mutantcells (negative log2 fold change values) < 1.0 are indicated in red and bold. Forselected genes, the approximate distance from the telomere end is indicated forcomparison. Open reading frames not yet characterized in C. albicans, butidentified as an orthologue of a Saccharomyces cerevisiae protein by the CandidaGenome Database website are indicated with “Sc” preceding the gene name.
Telomere:
approx.
distance
from end
Gene 
name Systemati
c name 
Gene functions / homologies  
Mean 
log2 
FC 
(YPD
) 
Mean 
log2 
FC 
(H2O2
) 
chrR R      
CTA26 
orf19.768
0 
Putative transcriptional activator, 
tel-proximal gene family 0.39 0.24 
ATP16 
orf19.767
8 
ScATP16; mitochondrial ATP 
synthase -1.35 0.09 ~2kb
XYL2 
orf19.767
6 
xyulose reductase, stress induced 
(scSOR1; Sorbitol dehydrogenase) 1.03 1.42 
 
orf19.767
5 
(scMRPL25; Mitochondrial 
ribosomal protein of the large 
subunit) 0.23 0.31 
 
orf19.767
3 (scSMD1; RNA splicing factor) -1.61 -0.22 ~4.5kb
 
orf19.767
2 
(scDFM1; ER unfolded protein 
response)  1.02 0.20 
 
orf19.767
0 
Putative Ca2+/H+ antiporter 
(scVNX1) 0.27 0.31 
MAL2 
orf19.766
8 
Alpha- glucosidase that hydrolyzes 
sucrose 0.47 0.68 
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IAH1 
orf19.766
7 Involved in acetate metabolism 0.03 0.18 
 
orf19.766
6 Anion:cation symporter (scSEO1) -0.67 -0.44 
 
orf19.766
5 
(ScCox16; Mitochondrial inner 
membrane protein, required for 
assembly of cytochrome c oxidase) 0.30 -0.09 
 
orf19.766
4  -0.42 -0.24 
 
orf19.766
3 
(ScCSM1; Nucleolar protein that 
forms a complex with Lrs4p and 
then Mam1p at kinetochores 
during meiosis I to mediate 
accurate homolog segregation) -0.10 0.02 
RTT10
3 
orf19.766
2 
(ScRTT103; plays a role in 
transcription termination by RNA 
polymerase II) 0.02 0.07 
HMI1 
orf19.766
1 
ATP-dependent 3' - 5' helicase 
involved in maintenance of 
mitochondrial DNA 0.00 0.04 
     
chrR L      
 
orf19.754
5  -0.18 0.08 
TLO1 
orf19.754
4 tel-proximal gene family -0.37 0.01 ~15 kb
INO2 
orf19.753
9 transcription factor  0.92 0.24 
PIF1/2 
orf19.753
8 
(scRRM3; DNA helicase involved 
in rDNA replication) 0.40 0.30 
BNR1 
orf19.753
7  0.15 0.31 
MIS12 
orf19.753
4  -0.09 -0.24 ~24 kb
 
orf19.753
1 Hyphae-induced  1.74 -0.08 
EPL1 
orf19.752
9 
Subunit of the NuA4 histone 
acetyltransferase complex 0.16 0.04 
chr1 L      
 
orf19.611
5 dubious ORF 0.18 0.01 
 
orf19.611
4 dubious ORF 0.39 0.32 
 
orf19.611
3 dubious ORF 0.05 0.44 
CTA2 orf19.611 Putative transcriptional activator , -0.72 0.20 
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2 tel-proximal gene family 
 
orf19.611
0 dubious ORF 0.13 0.66 
TUP1 
orf19.610
9 Transcriptional corepressor -0.01 0.31 
MVD 
orf19.610
5 
Mevalonate diphosphate 
decarboxylase -0.36 0.27 
 
orf19.610
3 
(ScSPO73; Meiosis-specific 
protein of unknown function) -0.21 0.02 ~15 kb
 
orf19.610
2 
(ScACA1; Transcription factor of 
the ATF/CREB family)  0.14 0.51 
chr1 R      
 
orf19.727
8 similar to Tca2 retrotransposon -0.53 -0.25 ~1 kb
TLO4 
orf19.727
6.1 tel-proximal gene family -0.54 0.97 
FGR24 
orf19.727
5 
Protein encoded in retrotransposon 
Zorro2 with similarity to retroviral 
endonuclease-reverse transcriptase 
proteins 0.09 0.10 
 
orf19.727
4 
Predicted ORF in retrotransposon 
Zorro2 with similarity to retroviral 
reverse transcriptase proteins 0.44 0.11 
 
orf19.727
2 dubious ORF 0.08 0.10 
 
orf19.727
1 dubious ORF 0.09 0.38 
 
orf19.727
0  -0.38 0.00 
PAA11 
orf19.726
9 
(ScPAA1; Polyamine 
acetyltransferase) -0.03 0.21 
 
orf19.726
7  0.67 0.04 ~10 kb
 
orf19.726
6  0.66 0.41 
UBP10 
orf19.726
5  -0.18 0.23 
RPN11 
orf19.726
4 
(ScRPN11; Metalloprotease 
subunit of the 19S regulatory 
particle of the 26S proteasome lid) 0.65 0.44 
 
orf19.726
3  -0.24 0.49 
GDI1 
orf19.726
1 
(ScGDI1; GDP dissociation 
inhibitor, regulates vesicle traffic 
in secretory pathways) -0.21 -0.07 
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chr2 R      
 
orf19.537
0  -0.41 0.31 
HEM1
2 
orf19.536
9 
(ScHEM12; Uroporphyrinogen 
decarboxylase) -0.02 -0.13 
 
orf19.536
8 
(scYDR049w; putative 
transcription factor) 0.09 0.20 
RDH5
4 
orf19.536
7 
Protein described as having role in 
DNA recombination, repair 0.39 -0.11 
 
orf19.536
5  -0.50 -0.13 
ECM2 
orf19.536
4 
(ScECM2; Pre-mRNA splicing 
factor) -0.31 -0.35 
chr2 L      
TLO5 
orf19.192
5 tel-proximal gene family -0.68 0.16 
RRN3 
orf19.192
3 
(ScRRN3; Protein required for 
transcription of rDNA by RNA 
polymerase I) 0.32 0.15 
CIS301 
orf19.192
0 
(ScYJL160c; member of the PIR 
(proteins with internal repeats) 
family of cell wall proteins) 0.35 -0.13 
AES6 
orf19.191
7  -0.01 0.10 
MPP10 
orf19.191
5 
(ScMPP10; Component of the 
SSU processome and 90S 
preribosome) -0.35 -0.17 
FAV3 
orf19.191
4 
Induced by mating factor in 
MTLa/MTLa opaque cells -0.26 -0.01 
 
orf19.191
3  -0.07 -0.13 
PGA52 
orf19.191
1 Putative GPI-anchored protein 0.10 -0.27 
 
orf19.191
0  0.40 -0.02 ~15 kb
EMC9 
orf19.190
7   0.68 0.30 
chr3 L      
 
orf19.547
5 dubious ORF -0.13 0.52 
 
orf19.547
4 dubious ORF 0.34 0.22 
 
orf19.547
2 dubious ORF 0.14 0.00 
YRF1 orf19.546  0.62 0.66 
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9 
TLO7 
orf19.546
7 tel-proximal gene family -0.44 0.33 
RPS24 
orf19.546
6 Predicted ribosomal protein 0.08 0.05 
YJU2 
orf19.546
5 
(ScYJU2; Essential protein 
required for pre-mRNA splicing) -0.39 0.01 ~17 kb
 
orf19.546
4   1.03 0.01 
SEC6 
orf19.546
3 
(ScSEC6; Essential 88kDa subunit 
of the exocyst complex) -0.12 -0.13 
chr3 R      
 
orf19.619
2 dubious ORF 0.79 0.26 
TLO8 
orf19.619
1 tel-proximal gene family -0.71 0.25 
SRB1 
orf19.619
0 
Essential GDP-mannose 
pyrophosphorylase -0.16 0.06 
FMP22 
orf19.618
9  -0.12 -0.02 
 
orf19.618
8  0.11 -0.14 
 
orf19.618
7  -0.03 -0.08 ~10kb
 
orf19.618
6  0.86 0.89 
IND1 
orf19.618
5  0.11 -0.30 
 
orf19.618
4  -0.02 0.42 
chr4L      
TLO9 orf19.362 tel-proximal gene family 0.48 0.76 
VMA6 orf19.364 vacuolar ATPase 0.46 0.71 
RAD1
7 orf19.366 
(ScRAD17; Checkpoint protein, 
involved in the activation of the 
DNA damage and meiotic 
pachytene checkpoints) -0.04 0.46 
CNH1 orf19.367 Na+/H+ antiporter -0.37 -0.38 
 orf19.371  -0.17 0.32 
 orf19.372  0.36 0.48 
 orf19.374 
(scTRE2; Protein that functions 
with Tre1p to regulate 
ubiquitylation and vacuolar 
degradation of the metal 
transporter Smf1p) -0.80 -0.08 
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BDA1 orf19.376  1.22 0.21 
PHR3 orf19.377 
(ScGAS4; 1,3-beta-
glucanosyltransferase) 0.10 0.19 ~16 kb
 
orf19.563
3  -0.43 0.52 
FRP1 
orf19.563
4 Predicted ferric reductase 0.24 0.59 
chr4R      
 
orf19.307
3  0.35 0.08 
TLO10 
orf19.307
4 tel-proximal gene family -0.18 0.21 
 
orf19.307
6 
(ScTVP15; Integral membrane 
protein localized to late Golgi 
vesicles) -0.87 -0.03 ~6.5kb
VID21 
orf19.307
7 
Subunit of the NuA4 histone 
acetyltransferase complex  -0.31 0.59 
 
orf19.308
0  0.54 0.90 
 
orf19.308
4  -0.16 0.32 
CDC1 
orf19.308
3 
(ScCDC1; Putative lipid 
phosphatase of the endoplasmic 
reticulum) 0.96 0.45 ~16kb
SEC10 
orf19.308
6 
(ScSEC10; Essential 100kDa 
subunit of the exocyst complex)  -0.81 -0.27 
chr5L      
TLO11 
orf19.570
0 tel-proximal gene family -0.39 0.36 
 
orf19.569
8 
Putative ribosomal protein 
(ScMRPL1) -0.10 -0.11 ~6.5kb
GAA1 
orf19.569
3 
(ScGAA1; Subunit of the 
GPI:protein transamidase 
complex)   0.10 0.63 
 
orf19.569
2  0.03 0.00 
CDC11 
orf19.569
1 Septin -0.15 0.38 
 
orf19.568
9 
(ScSEC28; Epsilon-COP subunit 
of the coatomer) -0.48 0.29 
 
orf19.568
8 absent from array   ~12 kb
 
orf19.568
6   0.97 1.44 
THS1 
orf19.568
5 Putative threonyl-tRNA synthetase -0.43 -0.12 
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orf19.568
4.1 absent from array   
 
orf19.568
4 
(ScMRPL28; Mitochondrial 
ribosomal protein of the large 
subunit) 0.05 0.15 
 
orf19.568
3 
(ScYHR140W ; Putative integral 
membrane protein) 0.56 -0.31 
chr5R      
 
orf19.405
5 
Protein similar to S. cerevisiae 
Ybr075wp -0.05 0.48 
CTA24 
orf19.405
4 Putative transcriptional activator -0.69 0.21 
HTS1 
orf19.405
1 Putative tRNA-His synthetas -0.42 0.03 
DES1 
orf19.404
8 delta-4 sphingolipid desaturase 0.11 -0.55 
EST1 
orf19.404
5 Telomerase subunit -0.19 -0.28 
 
orf19.404
6 
Putative transcription factor 
containing a Zn(2)-Cys(6) 
binuclear cluster 0.44 0.20 ~10 kb
MUM2 
orf19.404
4 
Protein similar to S. cerevisiae 
Mum2p  0.55 0.34 ~11 kb
 
orf19.404
3  0.32 0.69 
chr6L      
NRG2 
orf19.633
9 
Protein similar to ScNrg2p 
transcription factor, which 
regulates invasive growth in S. 
cerevisiae 0.03 0.16 
 
orf19.633
8 dubious ORF 0.43 0.24 
TLO13 
orf19.633
7 tel-proximal gene family 0.12 0.63 
PGA25 
orf19.633
6 Putative GPI-anchored protein -0.09 0.18 
 
orf19.632
9  -0.23 -0.15 
 
orf19.632
8 
(ScACN9; Protein of the 
mitochondrial intermembrane 
space) -0.23 0.05 
HET1 
orf19.632
7 
Putative sphingomyelin transfer 
protein -0.79 -0.16 
 
orf19.632
6  -0.34 0.38 
81
~13kb
 
orf19.632
5.1  0.76 0.64 
VID27 
orf19.632
4 
Protein similar to S. cerevisiae 
Vid27p -0.09 0.02 
HPA2 
orf19.632
3 
(ScHPA3; D-Amino acid N-
acetyltransferase) -0.34 0.19 
chr6R      
 
orf19.216
3 
(scYBR074w; Putative 
metalloprotease) 0.26 0.41 
NAG4 
orf19.216
0 
Putative transporter, N-
AcetylGlucosamine -0.09 0.75 
NAG3 
orf19.215
8 
Putative transporter, N-
AcetylGlucosamine 0.01 -0.35 
DAC1 
orf19.215
7  -0.04 -0.18 
NAG1 
orf19.215
6 
N-acetylglucosamine-6-phosphate 
(GlcNAcP) deacetylase 0.76 0.64 
HXK1 
orf19.215
4 
N-acetylglucosamine (GlcNAc) 
kinase 0.22 0.38 
NAG6 
orf19.215
1 N-AcetylGlucosamine -0.16 0.33 
chr7L      
 
orf19.712
5  -0.18 0.24 
RVS16
1 
orf19.712
4 Required for endocytosis -0.11 0.25 
 
orf19.712
3  0.33 0.06 ~3kb
 
orf19.712
1  0.76 0.31 ~6kb
RAD3 
orf19.711
9 
5' to 3' DNA helicase, involved in 
nucleotide excision repair and 
transcription  0.96 0.64 
ADK2 
orf19.711
8 
(ScADK2; Mitochondrial 
adenylate kinase) -0.45 0.10 
 
orf19.711
6 
(ScLEO1; Component of the Paf1 
complex) -0.70 -0.43 
SAC7 
orf19.711
5 
Protein described as a GTPase 
activating protein for RHO1 0.38 0.00 
CSA1 
orf19.711
4 
Surface antigen on elongating 
hyphae and buds -0.64 0.21 
FRP2 
orf19.711
2 
Protein described as ferric 
reductase 0.12 0.02 ~16kb
SOD3 
orf19.711
1.1 
Cytosolic manganese-containing 
superoxide dismutase  0.64 1.29 
82
FIS1 
orf19.711
1 
(ScFIS1; Protein involved in 
mitochondrial membrane fission 
and peroxisome abundance) -0.20 0.34 
chr7R      
TLO16 
orf19.712
7 tel-proximal gene family -0.41 0.47 ~6.5kb
 
orf19.712
7.1  0.66 0.76 
SYS1 
orf19.712
8 
(ScSYS1; Integral membrane 
protein of the Golgi) -0.17 0.03 ~8kb
 
orf19.713
0  1.10 -0.33 
BBH1 
orf19.713
1 Butyrobetaine dioxygenase 0.74 0.39 
SPT6 
orf19.713
6 transcription elongation factor -0.61 -0.32 
 
orf19.713
9  0.10 0.22 
CMT1 
orf19.714
0  0.42 0.55 
UFE1 
orf19.714
1 
Possibly involved in retrograde 
transport between the Golgi and 
the ER 0.31 -0.07 
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Available online athttp://www.pnas.org/content/107/4/1594/suppl/DCSupplemental
Supplemental Table 2.S7: List of gene ontology terms enriched in microarraydata from cells grown in YPD media. GO terms with at least ten associated genesin the genome and B.H. adjusted p-­‐value < 0.01 were included, calculated forgenes with RNA levels changed by log2 ≤ -­‐1 or log2 ≥ 1 with a p-­‐value < 0.01.
Supplemental Table 2.S8: List of gene ontology terms enriched in microarraydata from cells exposed to hydrogen peroxide. GO terms with at least tenassociated genes in the genome and B.H. adjusted p-­‐value < 0.01 were included,calculated for genes with RNA levels changed by log2 ≤ -­‐1 or log2 ≥ 1 with a p-­‐value < 0.01.
Supplemental Table 2.S9: Array-­‐wide microarray data in GEO “Matrix” formatfor the four biological replicates of YPD-­‐grown cells.
Supplemental Table 2.S10: Array-­‐wide microarray data in GEO “Matrix” formatfor the four biological replicates of H2O2-­‐exposed cells.
 
 
84
Supplemental Methods:
Deletion of RTT109 in C. albicansTo delete ORF19.7491 (RTT109) by gene replacement, we digested pSFL2 (Reusset al., 2004) to release the FRT-­‐flanked MAL promoter-­‐driven FLP and SAT1 drugresistance (natR) cassette. This cassette was inserted between 460 bp ofgenomic DNA flanking both sides of the C. albicans RTT109 open reading frame,yielding pPK564. We transformed SC5314 by electroporation as previouslydescribed (Reuss et al., 2004) with SmaI-­‐digested pPK564. Cells were recoveredon YPD agar overnight and replica plated onto YPD supplemented with 200 µgml-­‐1 nourseothricin (nat). We verified proper insertion of the construct at the
RTT109 locus by PCR using oligonucleotides targeted outside the region ofhomology (OPK1110 & OPK1111) and inside pPK564 (OPK1112) (Fig. 2.S1b and2.S1c; Table 2.S3; data not shown). To induce FRT-­‐specific recombination, wegrew the cells overnight in YEP supplemented with 2%maltose, plated singlecolonies on YPD agar and identified clones that lost resistance to nourseothricin.We verified deletion of the FLP, SAT1 insert by PCR using the oligonucleotidesmentioned above to identify a heterozygous RTT109 +/-­ strain (data not shown).We were not able to disrupt the second RTT109 gene using the strategydescribed above, suggesting that deletion of both RTT109 alleles is heavilyselected against, and that traditional insertional mutagenesis may be tooinfrequent in this case. Therefore, we took a two-­‐step approach, first replacingthe remaining RTT109 gene with one flanked by FRT sites. To do this, we made a
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2xFLAG-­‐6xHis tagged RTT109 allele adjacent to the SAT1 drug resistance gene,flanked by FRT sites and 460 bp of homology downstream and upstream the
RTT109 ORF (pPK585, carrying what we term the FLP-­‐Sensitive RTT109FS allele).We replaced the remaining copy of RTT109 in the heterozygous strain with
RTT109FS by introducing SmaI-­‐digested pPK585 by electroporation and selectingnatR colonies as described above. We verified proper insertion by PCR (Fig.2.S1c). We also confirmed the presence of the 6xHis-­‐2xFLAG-­‐tagged Rtt109protein in this isolate (PKA8) by metal affinity chromatography andimmunoblotting (data not shown). To provide an inducible source of FLP, weconstructed pPK592 by replacing the URA3 gene in pSFL213 (Staib et al., 2000)with the IMH3 (MPAR) gene, generating a SAP2 promoter-­‐driven FLP selectablewith mycophenolic acid (MPA). We transformed PKA8 with XbaI-­SacI-­‐digestedpPK592 by electroporation and selected on YNB media supplemented with 10 µgml-­‐1 MPA, yielding PKA11. Finally, to generate rtt109 -­‐/-­‐ homozygous strains, weinduced SAP2 promoter-­‐driven transcription of eCaFLP by growing PKA8 cells inYCB media supplemented with 10 µg ml -­‐1 MPA overnight, and screened for lossof the RTT109FS allele by determining which colonies displayed nourseothricinsensitivity. Candidate homozygous delete mutants were then screened by PCRand immunoblotting, yielding PKA13 (Fig. 2.S1c and Fig. 2.1a).The complemented strain, RTT109 FH/-­‐ (PKA15), was made by inserting an
RTT109-­‐2xFLAG-­‐6xHis allele (abbreviated as RTT109FH) into PKA13 at apreviously deleted rtt109D::FRT endogenous locus. To ensure this allele would
86
be stable in the presence of FLP, we removed both flanking FRT sites frompPK585, yielding pPK602. pPK602 was digested with SmaI, electroporated intoPKA13 and natR colonies were selected as described for pPK585. Properinsertion was confirmed by PCR (Fig. 2.S1c), and complementation of Rtt109function was demonstrated by H3K56ac immunoblot (Fig. 2.1a) and metalchromatography followed by anti-­‐Flag immunoblot analysis to detect Rtt109-­‐2xFlag-­‐6xHis expression (data not shown).
RT-­PCRmicroarray validationRNA samples purified for microarrays were used for RT-­‐PCR. cDNA wasprepared from 2 μg RNA with SuperScript II Reverse Transcriptase (Invitrogen)with oligo dT (Sigma) following the manufacture’s instructions.
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CHAPTER 3 
Discovery of a specific Rtt109 chemical inhibitor 
 
Acknowledgement: The following chapter includes a description of some work done 
in collaboration with the Small Molecule Facility at UMass Medical School 
(Worcester, MA) and the Chemical Biology Platform at the Broad Institute 
(Cambridge, MA). Specifically, Dr. Hong Cao operated the robots at the UMass 
Small Molecule Facility during the pilot high throughput screen described below. The 
subsequent screen, also described below, was conducted at the Broad Institute by the 
Chemical Biology Platform group with proteins manufactured in our lab by a 
previous Research Assistant, Amie Jordan. Unless indicated, all other protein 
purifications and experimental procedures were performed by myself. 
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 Introduction 
Histone acetyl-transferase (HAT) enzymes catalyze post-translation 
modifications (PTM) through the transfer of an acetyl group from acetyl-coenzyme A 
(Ac-CoA) to the ε-amine group of a histone lysine residue. PTMs on histones, which 
include methylation, phosphorylation, ubiquitination, in addition to acetylation, have 
important consequences for genome stability and function (Reviewed in (Gardner et 
al., 2011; Kouzarides, 2007; Mersfelder and Parthun, 2006; Peterson and Laniel, 
2004; Ransom et al., 2010; Zhu and Wani, 2010)). For instance, acetylation of 
specific histone amino acids can promote appropriate gene expression (Brownell et 
al., 1996), chromatin conformation (Shogren-Knaak et al., 2006), DNA replication 
(Li et al., 2008) and DNA repair (Chen et al., 2008).  
Recently, Rtt109, a HAT enzyme solely conserved in the fungal kingdom, was 
shown to be required for fungal pathogenicity (Lopes da Rosa et al., 2010; Wurtele et 
al., 2010). Rtt109 is entirely responsible for histone H3 lysine 56 (H3K56) acetylation 
in yeast (Han et al., 2007a; Lopes da Rosa et al., 2010; Schneider et al., 2006; 
Xhemalce et al., 2007). H3K56 is located on the α-helix between the N-terminal tail 
and the histone fold domain of histone H3, making it one of few PTM sites not 
located on the unstructured N-terminal tail of histones. In vivo, the histone chaperone 
Asf1 is required to stimulate Rtt109 acetylation of H3K56 (Han et al., 2007a; Recht et 
al., 2006; Schneider et al., 2006). Also, Rtt109 forms a stable complex with a 
different histone chaperone, Vps75, a NAP1 (nucleosome assembly protein 1) family 
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protein. In vivo, Rtt109-Vps75 contributes to acetylation of H3K9, H3K23 and 
H3K27 but not H3K56 (Berndsen et al., 2008; Tsubota et al., 2007). However, in 
vitro, Rtt109-Vps75 efficiently acetylates H3K56 (Berndsen et al., 2008; Tsubota et 
al., 2007). Yeast cells incapable of acetylating H3K56 are extremely sensitive to 
DNA damage (Driscoll et al., 2007; Hyland et al., 2005; Lopes da Rosa et al., 2010; 
Masumoto et al., 2005; Xhemalce et al., 2007). Consequently, deletion of RTT109 in 
the pathogenic fungus Candida albicans causes hypersensitivity to the genotoxic 
effects of reactive oxygen species (ROS) released by phagocytic cells of the 
mammalian immune system (Lopes da Rosa et al., 2010). As a result, C. albicans 
rtt109 -/- cells are avirulent in the murine model of systemic candidiasis (Lopes da 
Rosa et al., 2010). 
In humans, systemic candidiasis results in approximately 40% mortality, 
despite currently available anti-fungal medications (Gudlaugsson et al., 2003). C. 
albicans infections are common in hospital settings, especially on implanted surgical 
devices and in immune-compromised patients (Neofytos et al., 2010; Pfaller and 
Diekema, 2007). Most clinical drugs used against C. albicans intervene with cellular 
membrane or wall integrity. Unfortunately, anti-fungal drug resistance is common in 
this organism, involving changes in membrane synthesizing pathways and rapid 
efflux of the drugs through cellular membrane pumps (Cannon et al., 2007; Cowen et 
al., 2002). Therefore, discovery of novel anti-fungal drugs to combat this public 
health issue is merited. Since, loss of RTT109 significantly abolishes C. albicans 
pathogenicity and Rtt109 is solely conserved in fungi, we reasoned that a specific 
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HAT inhibitor would serve as an appropriate new drug without affecting other HATs 
conserved throughout Eukaryotes. 
Rtt109 has limited primary sequence homology to the three known HAT 
families: P300/CBP, GNAT (Gcn5- related N-acetyl transferase) and MYST (MOZ, 
Ybf2/Sas3, Sas2, Tip60). Furthermore, Rtt109 does not possess the canonical Motif A 
(acetyl coenzyme A binding pocket) as seen in other HATs. However, Rtt109 has a 
similar tertiary fold structures as the mammalian HAT p300 and a similar central core 
structure to that of Gcn5 (Lin and Yuan, 2008; Stavropoulos et al., 2008; Tang et al., 
2008). Thus far, the catalytic mechanism of known HATs entails de-protonation of 
the target histone lysine residue to facilitate its nucleophilic attack on the acetyl group 
of acetyl-coA (Hodawadekar and Marmorstein, 2007; Liu et al., 2008). Current 
evidence supports that Rtt109, GNAT and MYST family enzymes use a sequential 
catalytic mechanism involving binding of the substrates to enzyme to form a ternary 
intermediate complex before these catalytic steps can occur (Albaugh et al., 2010; 
Berndsen et al., 2007; Tanner et al., 1999; Trievel et al., 1999). In contrast, p300 
operates a Theorell-Chance (“hit-and- run”) mechanism that involves association of 
the enzyme and acetyl-coA first, followed by transient association with the protein 
substrate (Liu et al., 2008). The transient association of p300 to its substrate correlates 
with its large pool of target proteins. Despite the similarities between Rtt109 and 
other HATs, previously described HAT inhibitors, specifically for p300, do not affect 
Rtt109 catalysis (Bowers et al., 2010; Tang et al., 2008). 
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 Here, I present the discovery of the first compound that specifically inhibits 
Rtt109 HAT activity, called KB7 (Kaufman-Broad #7). p300 or Gcn5 activities are 
not affected by KB7. KB7 has a Kiapp of 56 nM. Its mechanism of inhibition appears 
to be noncompetitve with regard to the histone substrate and uncompetitive regarding 
Ac-CoA. KB7 inhibits Rtt109 in the presence of either Vps75 or Asf1, and inhibits 
HAT reactions using either N-terminal histone peptide or histone tetramer substrates. 
Finally, KB7-treated cells exhibit hypersensitivity to the DNA damaging agent 
campthotecin (CPT), reminiscent of rtt109Δ mutant cells. Overall, the data presented 
strongly supports KB7 as an appropriate candidate for further development into a 
novel anti-fungal drug. 
 
Materials and Methods 
Protein expression and purification 
Recombinant S. cerevisiae 6xHis-Rtt109, 6xHis-Vps75 and co-expressed 
RTT109-VPS75 with a 6xHis tag on either protein were purified as previously 
described (Tsubota et al., 2007). Recombinant S. cerevisiae FLAG-epitope-tagged 
Asf1N (N-terminal amino acids 1-155) was purified as previously described 
(Daganzo et al., 2003). Recombinant Xenopus laevis Histone H3 and Histone (H3-
H4)2 tetramers were purified as previously described (Luger et al., 1999). All proteins 
were dialyzed into 20 mM Hepes, 7.5, 25 mM NaCl, 1 mM EDTA, 5% glycerol, 
ultracentrifuged at 100,000 x g for 45 minutes and stored in small aliquots at -80°C. 
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A construct encoding recombinant 6xHIS-2xFLAG-P300 (nucleotides 1196-
1808) was obtained from Dr. Sharon Cantor. The protein was expressed in BL21 E. 
coli cells and purified through Ni-NTA resin (Qiagen) using the manufacteur’s 
instructions. The peak elutions were pooled and dialyzed in 20 mM Hepes, 7.5, 25 
mM NaCl, 1 mM EDTA, 5% glycerol and 1 mM PMSF (phenylmethysulfonyl 
fluoride) and stored in small aliquots at -80°C. 
A construct encoding recombinant S. cerevisiae 6xHIS-GCN5 (CP921) was 
obtained from Dr. Craig Peterson (Boyer et al., 2002). BL21 E. coli cells transformed 
with CP921 were cultures at 37°C and diluted back to O.D.600nm = 0.01 in 4 x 1L at 
18°C overnight. Cells were induced with 0.2 M IPTG between O.D.600nm = 0.38-0.5 
for 4 hours at 28°C. Four cell pellets were collected and washed with 25 mL 50 mM 
NaPO4 pH 7.0, 100 mM NaCl, 1 mM benzamidine, 5 mM beta-mercaptoethanol. 
Gcn5 was precipitated with 70% NH4SO4 by slowly adding finely ground NH4SO4 
crystals at 4°C while stirring. The solution was centrifuged at 20,000 x g and the 
pellet was resuspended in 20 mM Hepes pH 7.5, 1 mM EDTA, 10% glycerol, 0.01% 
NP40. Gcn5 was dialyzed into 20 mM Hepes, 7.5, 1 mM EDTA, 5% glycerol (no 
salt), ultracentrifuged at 100,000 x g for 45 minutes and stored in small aliquots at -
80°C. 
 
Pilot high throughput screen 
Detailed description of the protocol is provided in Table 3.1. Briefly, the pilot 
HTS was conducted with recombinant proteins in a 384-well plate format consisting 
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of 25 nM Rtt109-Vps75 and 178 µM (H3-H4)2 tetramers. The compounds were 
added at a final concentration of 125 µM, 2% DMSO. The HAT reactions were 
initiated with 7.5 µM acetyl-coenzyme A (Ac-CoA) (Sigma Aldrich, catalogue # 
A2056). Inhibition was quantified by ELISA with respect to each plate’s positive 
control (2% DMSO), using a specific anti-serum raised against an H3K56ac peptide 
(21st Century Biochemicals, Marlboro, MA). 
 
Broad Institute High throughput screen 
High throughput screen: Using a BioRaptr robot (Beckman), 80 nM Rtt109-
Vps75 (or just reaction buffer) and 50 µM screening compound were joined in 1 µl. 
Reactions were initiated with the addition of 1 µl 120 µM H3n21 peptide, 150 µM 
Ac-CoA in reaction buffer. The final composition of the HAT reaction is 40 nM 
Rtt09-Vps75, 60 µM H3n21 peptide, 75 µM Ac-CoA and 25 µM screening compound 
in 50 mM Hepes 0.0005% Pluronic F-68, pH8.0. The reaction proceeded for 4 hours 
at RT° in a humid chamber. Released coenzyme A was detected by the addition of 0.5 
µl 370 µM ThioGlo1 in PBS, 0.0005% Pluronic pH 7.4, for a final volume of 2.5 µl at 
74 µM. After 10 minutes at RT°, plates were read at ex380/em510 on an Envision 
(Perkin Elmer) plate reader. Each compound was tested twice. Hits were determined 
as causing >50% inhibition in duplicate. For data points where only a single reading 
was available, hits were also determined if >50% inhibition was observed. 
Cherry Picks: From the HTS, 537 hits were cherry picked for re-testing. Only 
449 compounds were available. These compounds were tested 2-3 individual times in 
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8-point 2-fold dose titrations ranging from 20-0.156 µM in 384-well clear bottom 
black plates. The reactions were prepared by adding 0.1 µl compound to 25 µl 200 
nM Rtt109-Vps75 (or just reaction buffer). The enzyme complex and compound were 
incubated at RT° for 10 minutes. Reactions were initiated with the addition of 25 µl 
120 µM H3n21 peptide, 150 µM ac-CoA in reaction buffer. The final composition of 
the HAT reaction was 100 nM Rtt09-Vps75, 60 µM H3n21 peptide and 75 µM Ac-
CoA in 50 mM Hepes 0.0005% Pluronic F-68, pH 8.0. The reaction proceeded for 2 
hours at RT°. Released coenzyme A was detected by the addition of 10 µl 4 mM 
Ellman’s Reagent (DTNB) in PBS, 0.0005% Pluronic pH 7.4, for a final volume of 
60µl at 0.66 µM. After 10 minutes at RT°, plates were read at absorbance 405 nm on 
an Envision (Perkin Elmer) plate reader. 
Powders: Thirty-two compounds were chosen from the cherry pick data to re-
test as freshly ordered powders. Twenty-eight of these were chosen based on yielding 
an IC50 ≤ 20 µM and having medicinal chemistry potential. Four additional 
compounds were chosen based on chemical expertise. The powder re-test was 
performed similarly to the cherry picks done in duplicate 8-point dose responses. The 
criterion for powder re-test was IC50 < 10 µM. 
 
HAT-ELISA assay 
End-point enzyme assays analyzed by ELISA were performed with 50 nM 
Rtt109 and 50 nM Vps75 or 400 nM Asf1-N terminus (amino acids1-155) or 15 
µg/mL p300. 300 nM (H3-H4)2 tetramer substrate was provided. Reactions were 
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initiated with 30 µM Ac-CoA (Sigma Aldrich, catalogue # A2056). Briefly, the 
protein mix was assembled on ice in 50 mM Tris, pH 8.0, 0.1 mg/ml BSA, 1 mM 
DTT to a volume of 323.4 µl. 3.3 µL of Dimethylsulfonate (DMSO) or 100x KB7 
was added for a final concentration of 1% DMSO in the reactions. The reaction was 
placed at 30°C for 5 minutes to allow temperature equilibration before initiating with 
3.3 µL of 100x (= 3 mM) Ac-CoA. After 30 minutes, the reactions were placed on ice 
and 100 µL were plated in triplicate on Immulon B 96-well ELISA plates. The plate 
were stored overnight at 4°C. 
Reactions were decanted and non-specific binding by the antibodies was 
prevented by incubating the wells with 200 µL 1% BSA, 0.05% tween-20, TBS for 1-
2 hrs at 4°C. ELISA detection was performed with 100 µL per well of rabbit anti-
serum raised against an H3K56ac peptide (21st Century Biochemicals, Marlboro, 
MA) diluted at 1:5000 in ELISA buffer (0.05% tween-20, TBS) for 1-2 hrs at 4°C. 
Anti-rabbit HRP-conjugated IgG was used at 1:2500 in ELISA buffer for 100 µL per 
well for 1 hr at 4°C. Washes before and after antibody incubations were performed 3 
x 200 µL per well with ELISA buffer. 
 
HAT- ThioGlo1 assay 
Kinetic measurements of HAT reactions were performed using 50 nM co-
expressed Rtt109-Vps75, 15 µM Histone H3 N-terminal peptide residues 1-21 
(H3n21; 21st Century Biochemicals, Marlboro, MA. Cat# H3 1-21NT) and 30 µM 
Ac-CoA (Sigma Aldrich), unless otherwise indicated. In place of R-V, 15 µg/mL 
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p300 or 3.07 µg/mL Gcn5 was used. Reactions were assembled on ice in 20 mM 
Hepes, pH 7.5, 0.01% NEM-treated BSA (Trievel et al., 2000), 0.01% triton X-100 to 
a volume of 646.8 µL in glass tubes. 6.6 µL of Dimethylsulfonate (DMSO) or 100x 
KB7 was added for a final concentration of 1% DMSO. Unless otherwise indicated, 
the reaction was place at 30°C for 5 minutes to allow temperature equilibration before 
initiating with 3.3 µL of 100x (=3 mM) Ac-CoA. 120 µL samples were collected at 2, 
4, 6, 8 and 10 minutes after initiation, directly added to 120 µL ice cold isopropanol 
and vortexed. Stopped reaction time-points were stored at -20°C until further use. 
The amount of released coenzyme A upon acetylation was quantified at each 
collected time point as previously described (Trievel et al., 2000) and plotted on 
Prism GraphPad software. Briefly, released coenzyme A is detected by a maleimide 
reagent (ThioGlo1; EMD, catalogue #595501) which fluoresces upon binding to the 
free sulfhydryl exposed on coenzyme A, but not on Ac-CoA. Rates were determined 
by comparison with standard curves of fluorescence obtained with known amounts of 
Coenzyme A (CoA; Sigma Aldrich, catalogue #c3144). Two-fold serial dilutions 
from 6- 0.5 µM CoA were prepared in HAT reaction buffer for each plate, and an 
equal volume of isopropanol was added. To measure fluorescence, 100 µL per well of 
the stopped reactions or standards (in duplicate or triplicate, respectively) were plated 
in FluoTrac200 medium-binding black plates (Greiner, VWR, catalogue # 655076). 
100 µL of 30 µM ThiolGlo1 diluted in 1% Triton X-100 was added and mixed by 
pipetting. The plate was incubated at RT° for 30 minutes in the dark and read at 
ex384/em513. 
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To determine mode of inhibition, reaction rates versus substrate concentration 
were fitted to a non-linear regression curve and analyzed using the Michaelis-Menten 
equation by Prism GraphPad. Three concentrations of inhibitor were tested per 
experiment for each substrate, including a 1% DMSO control (no inhibitor). Eight 
concentrations of substrate were tested per concentration of inhibitor. Due to day-to-
day variation in reaction rates, a single representative experiment is shown for each 
substrate titration. The trends and conclusions between the individual experiments are 
consistent. 
 
Microtiter broth growth assay 
  Overnight yeast cultures grown in YPD at 30 °C were diluted to 0.1 O.D.600 nm 
and allowed to exit lag phase for 2 hrs. C. albicans cells were transferred to 37°C 
after those initial 2 hrs. C. albicans cells were allowed to grow for 4- 5 hrs in log-
phase then diluted back to 0.04 O.D.600 nm. 100µL cells were plated onto 96-well non-
tissue culture treated sterile plates in triplicate. The indicated concentrations of 
camptothecin diluted in 1.5 N NaOH (or the equivalent amount of NaOH without 
drug) and KB7 diluted in DMSO (or 1 % DMSO alone) were added to a final volume 
of 200 µL per well. The plates were incubated at 37°C in a temperature-controlled 
spectrometer (Synergy HT, Bio-Tek) and O.D.595 nm was measured every 30 minutes 
for 19 hrs. Growth rates were calculated using KC4 data analysis software (Bio-Tek). 
 
RESULTS 
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Pilot high-throughput screen for Rtt109 inhibitors 
 In order to test the feasibility of finding Rtt109 inhibitors using an in vitro 
histone acetyl-transferase (HAT) assay, I developed a pilot high-throughput screen 
(HTS) to query the 30,000-compound library at the Small Molecule Facility, UMass 
Medical School (Worcester, MA). The compounds were queried at 125 µM against 
the Rtt109-Vps75 (R-V) complex. Levels of acetylated H3K56 (H3K65ac) on (H3-
H4)2 tetramers after an end-point HAT assay were detected by ELISA using a 
specific anti-H3K56ac anti-serum. The pilot screen averaged a z-factor score of 0.9 
per plate and had an initial hit rate of 0.52% with a cutoff of 75% inhibition. Ninety-
three primary candidates were repurchased for manual testing. Of these, 8 exhibited ≥ 
75% inhibition at 25 µM using a fluorescent detection reagent (ThioGlo1) that 
quantitatively detects the free sulfhydryl of the coenzyme A released during the 
acetyl-transferase reaction.  
From this pilot screen, the most potent of these eight candidate compounds, 
termed iPK38, displayed a 50% inhibitory concentration (IC50) value of 4.5 µM and 
displayed noncompetitive inhibition with respect to both histone H3n21 peptide and 
Ac-CoA substrates (data not shown). However, iPK38 proved to be inhibitory 
towards all categories of enzymes tested, including restriction endonucleases (data 
not shown). Since iPK38 has the same chemical backbone (quinoxaline) as half of the 
potent inhibitors obtained in this pilot screen, and other potent inhibitors with 
different chemical backbones were also non-specific, I concluded that a more 
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sophisticated library needed to be queried to find specific inhibitors of Rtt109 at low 
micromolar range. 
 
High-throughput screen conducted at the Broad Institute 
In collaboration with the Chemical Biology Platform at the Broad Institute 
(Cambridge, MA), we screened 363,843 small molecules at 25 µM for inhibitors of 
Rtt109 catalysis in end-point HAT assays. The pilot HTS developed in our laboratory 
using the ThioGlo1-based fluorescent detection of the free sulfhydryl group on 
released coenzyme A was adapted at the Broad Institute to a 1536-well plate format. 
The HTS was performed in duplicate, and 224 out of 333,734 compounds yielded > 
50% inhibition (0.07% hit rate). For those compounds where only a single 
measurement was available, 313 out of 30,109 yielded > 50% inhibition (1% hit rate). 
Of these initial hits, 449 compounds were readily available for re-testing in 8-point 2-
fold dose titration. In this case, the free sulfhydryl groups of released CoA were 
detected using Ellman’s reagent (DTNB), via optical absorbance. Using Ellman’s 
reagent should therefore control for non-specific fluorescence quenchers obtained in 
the initial screen. We observed that 83 compounds produced a dose-dependent 
response with an estimated IC50 ≤ 20 µM. Thirty-two of these compounds were 
chosen to re-test as freshly ordered powders based on their medicinal chemistry 
potential. Again, these compounds were tested in 8-point 2-fold dose response curves. 
Nine of these compounds exhibited IC50 values below 10 µM. These nine 
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compounds were sent to our laboratory for further characterization and inhibition 
kinetics studies. 
 
KB7 is a specific inhibitor to Rtt109 catalysis 
 To test the specificity of the 9 most potent inhibitor candidates, I performed 
enzyme inhibition kinetic assays comparing Rtt109-Vps75 and p300 in the presence 
of 0.5 – 2 µM compound (Table 3.2). Only a single chemical, KB7 (Kaufman-Broad 
#7) inhibited Rtt109 without inhibiting p300. Two compounds (KB5 and KB9) 
appeared to inhibit the maleimide detection reaction based on no increase of 
fluorescence with time and similar low ex384/em513 raw values across all 4 
experimental conditions lower than protein background. KB7 specifically decreased 
R-V reaction rates by 80, 77, 87% with 2, 1, 0.5 µM, respectively, compared to 47, > 
0, > 0% for p300 rates. KB7 has the following chemical formula C22H23ClFN3O3 and 
structure as depicted in Figure 3.1A. (IUPAC name N-[(2-chloro-6-
fluorophenyl)methyl]-2-(2, 5-dioxo-4-phenyl-4-propylimidazolidin-1-yl)-N-
methylacetamide). 
To assess an IC50 value for R-V reaction rate, I performed HAT reactions 
with varying concentrations of KB7 and determined rates during the initial linear 
phase of the reaction. Each reaction rate was calculated via linear regression of 
product formed versus time (mean R2 = 0.91, ranging from 0.77-0.99). Non-linear fit 
of each reaction velocity plotted against KB7 concentration on a semi-log scale 
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Kaufman-Broad 
compound 
concentration 
(µM) 
% inhibition 
Rtt109-Vps75 
% inhibition 
p300 
1 3 16 59 
2 0.5 78 97 
2 100 99 
3 4 0 36 
4 4 50 73 
5** 2 97 100 
6 2 46 91 
7 0.5 87 > 0 
1 77 > 0 
2 80 47 
8 2 47 90 
9** 2 97 100 
Table 3.2 Initial assessment of chemical inhibitor (IC50 < 10 µM in end-
point assay) from HTS conducted at the Broad Institute. Percent reaction 
rates are reported as normalized to 1% DMSO (no inhibitor) reactions performed in 
parallel. ** Compounds believed to quench the ThioGlo1 detection reaction making 
these results inconclusive.   
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indicates an IC50 of 56.19 nM (1.28 nM SEM; 95% CI 33.25- 94.94 nM) and Hill 
slope coefficient of -1.09 (0.28 SEM) (R2 = 0.94) (Figure 3.1B).  
IC50 values could not be calculated for KB7 inhibition of p300 and Gcn5 
enzyme activity. As above, each reaction rate was determined via linear regression of 
product formed versus time (p300 mean R2 = 0.98, ranging from 0.97-0.99; Gcn5 
mean R2 = 0.97, ranging from 0.94-0.99). High concentrations of KB7 (up to 100 
µM) did not reduce enzyme reaction rates below 80% activity, with no apparent trend 
as KB7 concentration was increased (Figure 3.1C). Due to solubility limitations, KB7 
was not tested above 100 µM. It is, therefore, possible that stronger inhibition can 
occur at higher concentrations. 
 
KB7 inhibits Rtt109 H3K56 acetylation mediated by both Vps75 and Asf1 on 
(H3-H4)2 tetramers 
 In vivo, Rtt109-Vps75 (R-V) acetylates three H3 tail residues (K9, K23, and 
K27) (Berndsen et al., 2008; Burgess et al., 2010; Fillingham et al., 2008). Only 
Rtt109 associated with Asf1 (R-A) acetylates H3K56 to promote genome stability 
(Adkins et al., 2007; Driscoll et al., 2007; Han et al., 2007a; Han et al., 2007b; Recht 
et al., 2006; Schneider et al., 2006). Vps75’s contribution to H3K56ac in vivo is 
undetectable (Han et al., 2007c; Tsubota et al., 2007). However, in vitro, R-V very 
efficiently acetylates H3K56 (Tang et al., 2011; Tsubota et al., 2007). The R-V 
complex has a catalytic efficiency (Kcat/Km) 20-fold greater than R-A mediated 
catalysis in vitro (Tsubota et al., 2007) and Rtt109 has strong affinity towards Vps75 
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(Kd = ~10-23 nM; (Albaugh et al., 2010; Berndsen et al., 2008) allowing easy co-
expression and purification. Therefore, we chose to perform the HTS and enzyme 
inhibition studies using R-V. However, point mutation data from structural studies 
suggest that amino acid residues important for catalysis of R-V do not affect R-A 
(Tang et al., 2011). To determine whether KB7 also inhibits R-A mediated catalysis, I 
performed end-point HAT assays using (H3-H4)2 tetramers as the substrates. I then 
probed the histones for H3K56ac by ELISA using a specific anti-H3K56ac antibody. 
In this manner, inhibition of R-V and R-A catalysis were comparable at 87% and 
83%, respectively (Figure 3.2A). Importantly, this data also shows that acetylation of 
the core histone target (H3K56) is specifically inhibited by KB7, a conclusion that we 
could not make using the histone H3n21 peptide substrate and ThioGlo1 detection 
assay. 
Additionally, using the same end-point HAT-ELISA reaction with p300, I 
confirmed that p300 activity on histone substrates is not affected by KB7 for 
acetylation of H4 N-terminal residues (Figure 3.2B). This was another conclusion that 
could not be made using the peptide substrate, as P300 also acetylates non-histone 
proteins (Ogryzko et al., 1996). 
 
KB7 is a noncompetitive inhibitor regarding histone and Ac-CoA substrates 
 To determine the mechanism of inhibition of KB7, I performed enzyme 
kinetic studies by titrating Ac-CoA or H3n21 peptide in the presence of varying 
concentrations of the inhibitor. For each substrate, three independent experiments 
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Figure 3. 2. KB7 specifically inhibits H3K56 acetylation by both Rtt109-
Vps75 and Rtt109-Asf1. (A) Acetylation of H3K56 is inhibited by KB7. End-point HAT 
reactions were performed with 50 nM Rtt109, 300 µM (H3-H4)2 tetramers, 50 nM Vps75 or 
400 nM Asf1N(1-155), with DMSO (vehicle) or 500 nM KB7. Reactions were initiated with 15 
µM acetyl coEnzyme A  at 30°C for 30 minutes. Acetylated H3K56 was detected by ELISA. n 
= 2 (B) HAT activity of P300 is not inhibited by KB7. End-point reactions were performed 
with 15 µg/ml P300 as described in A. Acetylated histone H4 was detected by ELISA. n = 2. 
B
A
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were performed where titration curves with no inhibitor were compared to two 
concentrations of KB7. A single representative experiment for each substrate is 
presented due to day-to-day alterations in net velocity. However, trends and 
conclusions are consistent. 
H3n21 peptide was titrated from 0.5- 60 µM in the presence of 0, 40 and 80 
nM KB7. Reaction rates (average linear regression R2 = 0.89) were plotted and fit to 
the Michaelis-Menten equation (Figure 3.3A). Increasing amounts of KB7 reduced 
Vmax (0 µM KB7, 11.96 pmoles/ min; 40 µM KB7, 5.624 pmoles/ min; 80 µM KB7, 
3.852 pmoles/ min). Km was not consistently affected. Graphing the data using the 
Lineweaver-Burk (double reciprocal) plot yielded more detailed information (Figure 
3.3B). Indeed, KB7 decreases Vmax; Linear-regression of the data results in 
decreasing values of V for the y-intercept as KB7 concentration increases. The value 
for Km does not significantly change as the lines converge in the third quadrant. This 
result indicates that Kis > Kii, (where Kis= Kd for free enzyme-inhibitor and Kii= Kd 
for substrate-bound enzyme- inhibitor) (Purich and Allison, 2000), meaning the 
dissociation constant for Rtt109 and KB7 is greater than the dissociation constant for 
Rtt109-H3n21 and KB7. This result suggests that KB7 exhibits mixed inhibition, a 
type of noncompetitive inhibition where KB7 has greater affinity for the Rtt109-
H3n21 intermediate than for free Rtt109. In conclusion, both non-linear regression 
and double reciprocal linear plots agree that KB7 is acting noncompetitively towards 
the H3n21 substrate. These results signify that the inhibitor is not competing for the 
binding site of H3. 
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Ac-CoA was titrated in the same fashion from 0.5-10 µM at various 
concentrations of KB7. Reaction rates (average linear regression R2 = 0.95) were 
plotted and fit to the Michaelis-Menten equation (Figure 3.4A). KB7 reduced both 
Vmax (0 µM KB7, 8.122 pmoles/ min; 30 µM KB7, 4.319 pmoles/ min; 60 µM KB7, 
2.045 pmoles/ min) and Km (0 µM KB7, 1.607 µM; 30 µM KB7, 0.7726 µM; 60 µM 
KB7, 0.5994 µM). In a double reciprocal plot, the lines are parallel and do not 
converge at any point (Figure 3.4B), consistent with the change of both Vmax and 
Km. These data indicate a specific type of noncompetitive inhibition termed 
uncompetitive inhibition. Uncompetitive inhibition requires that the enzyme be bound 
to the substrate in question to accommodate the inhibitor. This conclusion would 
imply that Rtt109 must be bound to Ac-CoA (with or without H3n21 peptide) in order 
for KB7 to bind, suggesting that a conformational change may occur upon Ac-CoA 
binding. 
 
In vivo effects of KB7 
  The phenotype of yeast cells incapable of acetylating H3K56 either due to 
loss of functional Rtt109 or point mutations of H3K56 is hypersensitivity to 
genotoxic agents (Driscoll et al., 2007; Garcia et al., 2007; Hyland et al., 2005; Lopes 
da Rosa et al., 2010; Xhemalce et al., 2007). To determine if KB7 causes 
hypersensitivity to DNA damaging agents, growth rates of C. albicans cells exposed 
to 50 and 100 µM KB7 with or without the addition of 100 µM camptothecin (CPT) 
were monitored. CPT is a topoisomerase I poison that leads to double strand DNA 
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breaks. Wild-type C. albicans cells are extremely resilient to this dose of CPT, but 
rtt109-/- cells are sensitive even at 5 µM CPT (Figure 3.5A). We anticipated 
difficulties in introducing KB7 inside C. albicans because of its wide usage of cell 
membrane efflux pumps to rid itself of toxins. Therefore, we obtained and tested 
various efflux pump mutants from Dr. Dominique Sanglard that have reduced anti-
fungal drug resistance (Ramage, 2002). As shown in Figure 3.5A, cdr1-/-, cdr2-/- 
(DSY654; (Ramage, 2002)) mutants are already more sensitive to CPT compared to 
wild-type, suggesting that a mode of resistance to this DNA-damaging drug involves 
efflux pumps to rid the cells of the toxin. The CDR1, CDR2 genes encode ATP-
binding cassette (ABC) pumps that transport multiple drugs across the cellular 
membrane, specifically promoting azole drug resistance. More interestingly, the 
presence of KB7 causes a significant synergistic decrease in growth rate in cdr1-/-, 
cdr2-/- (DSY654; (Ramage, 2002)) mutants (p-values ≤ 0.05). As expected, KB7 had 
no effect on rtt109-/- cells and as suspected, no growth defect was detected in wild-
type cells (Figure 3.5A). 
rtt109-/- C. albicans cells have a moderate decrease in growth rate (30% 
decrease in doubling time compared to wild-type; Figure 2.1E; (Lopes da Rosa et al., 
2010)). cdr1-/-, cdr2-/- (DSY654; (Ramage, 2002)) cells exhibit clear growth defects 
on YPD plates embedded with 100 µM KB7 (Figure 3.5B). However, a synergistic 
effect with embedded 50 µM CPT is not noticeable. This could either be due to the 
severity of KB7’s effect alone or to 50 µM CPT being too low a concentration to 
cause sufficient DNA damage to this otherwise wild-type cell. Parallel treatment of 
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mdr1-/-, cdr1-/- (DSY468; (Ramage, 2002)) cells did not exhibit a growth defect. In 
addition, cdr2-/- (DSY653; (Ramage, 2002)) cells were tested in the microtiter broth 
assay and showed no phenotype (data not shown). Overall, this suggests that only 
upon deletion of both CDR genes is efflux action attenuated enough to allow 
intracellular accumulation of KB7 for an observable phenotype (Figure 3.5B).  
 
DISCUSSION 
Through a high-throughput screen in collaboration with the Broad Institute, I 
have identified a specific Rtt109 inhibitor, termed KB7. KB7 inhibits Rtt109 with an 
apparent IC50 of ~56 nM and is extremely specific to Rtt109 (Figures 3.1 and 3.2). I 
did not observe significant inhibition of other HATs such as P300 and Gcn5 even at 
KB7 concentrations of up 100 uM (Figure 3.1C and 3.2B), suggesting that there is at 
least two orders of magnitude of specificity for Rtt109. Importantly, KB7 inhibits 
H3K56 acetylation by Rtt109 activated by either Vps75 or Asf1 (Figure 3.2A). 
H3K56ac is the physiologically relevant PTM for genome stability and efficient 
pathogenicity of yeast in the face of DNA damage. Since structural studies suggest 
that Vps75 and Asf1 utilize distinct regions of Rtt109 (Tang et al., 2011), I am 
confident that KB7 does not simply block interaction between rtt109 and the histone 
chaperone, but in fact prevents catalysis. Furthermore, the ability of KB7 to inhibit R-
V mediated catalysis on H3n21 peptides, representing the N-terminal tail residue 
H3K9, and H3K56 on full-length histone H3 indicates that positioning of the histone 
by Vps75 is not restrictive to PTM sites. It supports the conclusion put forth by others 
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that Asf1 is indeed restrictive in PTM site presentation to Rtt109 for catalysis, 
allowing only H3K56 acetylation to occur (Lin and Yuan, 2008). 
The NIH PubChem database shows that KB7 has been tested in 348 
bioassays, but has only been active in one. In that case, 25 µM of KB7 reduced 
binding of an H4K20 tri-methylated peptide to a jumonji domain (PubChem CID 
4785700). Since KB7 concentration was 3 orders of magnitude above the interacting 
components, a possible conclusion for this result is sequestration of peptide or 
protein. In our case, KB7 is efficient at nanomolar range, equivalent to Rtt109 
concentration, when the substrates are at micromolar range. It is unlikely that 
sequestration of substrates is occurring. 
The inhibition mechanism of KB7 is complex. KB7 decreases the Vmax with 
respect to both Ac-CoA and H3n21 substrates, indicating that the substrates do not 
compete with the inhibitor to prevent inhibition (Figure 3.3 and 3.4). The inhibitor is 
therefore noncompetitive with respect to both substrates and most likely binds 
allosterically on Rtt109 to prevent catalysis without affecting either substrate (or 
chaperone) interaction. In more detail, KB7 lowers the Km for Ac-CoA, a behavior 
characteristic of uncompetitive inhibition (Figure 3.4). As an uncompetitive inhibitor 
towards Ac-CoA, KB7 can only bind the Rtt109-Ac-CoA intermediate, regardless of 
the presence of the histone peptide. With regards to the histone substrate, KB7 
behaves as a mixed inhibitor (Figure 3.3). KB7 may bind to free Rtt109 or Rtt109-H3 
intermediate. However, the double reciprocal plot indicates that Kis > Kii , signifying 
that KB7 has a greater affinity for the Rtt109- H3 intermediate over free Rtt109. 
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Unifying the two inhibitory mechanisms, one can imagine a model where KB7 
preferentially binds to the Rtt109-Ac-CoA- H3n21 ternary intermediate complex. 
KB7 may also bind to Rtt109-Ac-CoA with less affinity. This model is consistent 
with data showing that Rtt109 utilizes a random-ordered, sequential mechanism 
where either substrate can bind Rtt109 in random order to form a ternary complex 
prior to any catalytic steps (Albaugh et al., 2010). 
The goal in finding Rtt109 inhibitors is to provide a lead compound for 
medicinal chemistry alterations leading to a novel anti-fungal drug. During the course 
of an infection, pathogenic fungi are subjected to the DNA damaging effects of ROS 
by phagocytic cells. For C. albicans, Rtt109 is essential to survive ROS-mediated 
DNA damage by macrophages (Figure 2.3E; (Lopes da Rosa et al., 2010)). Most 
significantly, rtt109 -/- C. albicans cells are avirulent in systemic candidiasis (Figure 
2.3A and 2.3B; (Lopes da Rosa et al., 2010; Wurtele et al., 2010)), a bloodborne 
infection that leads to 49% mortality in humans (Gudlaugsson et al., 2003). On cells, 
KB7 causes synergistic growth rate defect with the DNA damaging agent CPT, albeit, 
only in the efflux pump mutant cdr1-/-, cdr2 -/- (DSY654; (Ramage, 2002)) (Figure 
3.5). However, this data is promising in indicating that Rtt109-mediated DNA 
damage resistance is compromised by KB7 and would therefore affect pathogenicity. 
Overall, this initial characterization of KB7 demonstrates outstanding possibilities for 
further development towards a novel anti-fungal agent. Future studies addressing 
structural activity relationships (SAR) will focus on improving permeability and 
retainment of the drug, in order to improve its effective intracellular potential. 
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CHAPTER 4 
Concluding Remarks 
 
Purpose and outcome 
 The contributions of chromatin to fungal pathogenesis are just beginning to be 
elucidated. It is evident from the studies previously discussed that repair of 
chromatin, transcriptional activation, and manipulation of genome plasticity all 
promote fungal pathogenicity. In particular, this dissertation focused on a fungal 
specific chromatin-modifying enzyme that promotes survival from DNA damage and 
genome stability. The first aim was to establish whether the function of this unique 
enzyme has biological relevance on pathogenicity. Second, the goal was to determine 
if this pathway could be exploited for development of novel anti-fungal drugs.  
By deleting both alleles of RTT109 in C. albicans, I showed that this 
particular histone acetyltransferase plays an important role in resistance to genotoxic 
stress during the course of an infection. This genetic deletion resulted in 100% 
survival of mice intravenously infected with rtt109-/- C. albicans cells 20 days post 
infection, compared to 0% survival in mice infected with wild-type cells by 7 days 
post infection (Figure 2.3B). Specifically, my data supports that the genotoxic stress 
caused by reactive oxygen species released from macrophages are detrimental to 
fungal cells unable to acetylate H3K56 (Figure 2.3E). The connection between 
H3K56ac and hypersensitivity to DNA damage had already been made in budding 
and fission yeast (Driscoll et al., 2007; Han et al., 2007a; Masumoto et al., 2005; 
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Recht et al., 2006; Xhemalce et al., 2007). The data in this dissertation were the first 
to demonstrate a similar role in a pathogenic fungus and it’s implication in 
pathogenesis (Chapter 2). 
Having established a role for Rtt109 and H3K56 acetylation in fungal 
pathogenesis, I switched my focus to identifying small molecule inhibitors of Rtt109 
catalysis. I employed a biochemical enzymatic-based high throughput screen. Out of 
~300,000 compounds, I identified a single chemical with inhibitory activity in the 
nanomolar range and specificity to Rtt109 (chapter 3). This chemical, KB7 reduces 
Rtt109 catalytic rate by 50% with just ~56 nM (Figure 3.1B). No significant effect 
was detected on p300 or Gcn5 catalysis at concentrations up to 3 orders of magnitude 
greater (Figure 3.1C and 3.2B). KB7 inhibits catalysis mediated by the 
physiologically relevant Rtt109-Asf1 reaction, acetylation of H3K56 on full-length 
histones and not just N-terminal tail modification mediated by Rtt109-Vps75 
complexes (Figure 3.2A). As a consequence, cells treated with KB7 exhibit 
significant reduction in growth rate in the presence of the DNA damaging agent, 
camptothecin (Figure 3.5A). The characterization of KB7 as an Rtt109 inhibitor is 
relatively preliminary in the scope of developing a novel anti-fungal agent. 
Nonetheless, this dissertation describes the first Rtt109 inhibitor, as thus far attempts 
to inhibit Rtt109 with other known HAT inhibitors have failed (Bowers et al., 2010; 
Tang et al., 2008). The specificity of this inhibitor, its potency and intracellular 
effectiveness make KB7 an outstanding lead compound to directly have come out of a 
chemical library from a high throughput screen. 
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 Implications 
It is evident that H3K56 acetylation is crucial for systemic candidiasis, but it 
is unlikely to be important at other sites of infection, specifically those without 
activated phagocytes. Circulating monocytes need to be activated by the adaptive 
immune system to differentiate into non-circulating resident macrophages. This 
means that in order to take advantage of an Rtt109 defect, the host immune system 
must be functional. Because a large demographic of people affected by opportunistic 
candidiasis infections are immuno-compromised, this limitation could be problematic. 
One way to circumvent this limitation is by combinatorial drug treatment. As shown 
in chapter 2, rtt109 -/- cells are sensitive to 5-flucytosine (5-FC), a nucleotide 
analogue that disrupts the pyrimidine salvage pathway and leads to genotoxic stress 
(Hope et al., 2004). 5-FC is already a clinically used drug used against C. albicans, 
however with caution due to a ~7-8% incidence of drug resistance (Vermes et al., 
2000). As such, 5-FC is recommended primarily for treatment of systemic candidiasis 
in combination with an additional anti-fungal drug (Vermes et al., 2000). In addition, 
rtt109-/- C. albicans cells are sensitive to some but not all classes of clinically 
approved anti-fungal drugs. rtt109 -/- cells are sensitive to echinocandins (caspofungin 
and micafungin) (Wurtele et al., 2010) which interfere with cell wall b-glucan 
synthesis. However, rtt109-/- mutants are not sensitive to azoles (fluconazole) and 
polyenes (amphothericin B) (Lopes da Rosa et al., 2010), both of which affect cell 
membrane integrity (Mishra et al., 2007). 
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An interesting line of research that has not been fully explored is not just the 
role of chromatin, but in general the role of DNA repair pathways in pathogens that 
promote pathogenesis. In C. albicans, Chauhan, et al. demonstrated that mutants 
unable to repair DNA through homologous recombination (rad52-/-) or non-
homologuos end-joining (lig4-/-) are avirulent (Chauhan et al., 2005). However, the 
authors’ emphasis was the role of these DNA repair pathways in generating genetic 
diversity, not survival from genotoxic stress. No subsequent follow-up studies were 
undertaken on the aspect of DNA damage and repair. In the field of Mycobacterium 
tuberculosis, DNA repair pathways as it pertains to pathogenesis is intensely being 
studied, as this bacterium lives inside macrophages and must therefore deal with 
DNA damage (Reviewed in (Dos Vultos et al., 2009; Gorna et al., 2010; Kurthkoti 
and Varshney, 2011)). It is accepted that DNA repair is vital to its pathogenesis. 
However, unlike M. tuberculosis, C. albicans is an extracellular pathogen. In fact, C. 
albicans colonizes mucosal lining, forms biofilms and damages tissue. However, 
when C. albicans cells are engulfed by macrophages, they readily escape a 
detrimental fate by filamenting and bursting out of the phagocyte (Lorenz et al., 
2004). Despite this difference, it is evident that from the data reported in this 
dissertation and from other work by Chauhan, et al. and Wurtele, et al. that 
hypersensitivity to DNA damage is detrimental to C. albicans pathogenicity 
(Chauhan et al., 2005; Wurtele et al., 2010). 
Future directions 
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 The discovery of a specific Rtt109 inhibitor is exciting in light of the 
biological consequences towards pathogenicity. However, the inability of KB7 to 
efficiently cross the cellular membrane of C. albicans is challenging. The immediate 
step to continue characterizing a lead compound from a high throughput screen is 
structural activity relationship (SAR) studies. We have already obtained 9 structurally 
similar compounds to KB7 in order to identify which functional groups are required 
for inhibition. Results from the SAR study may lead to a more permeable compound. 
However, it is more customary that permeability issues are dealt with purposeful 
alterations of the compound. Since chemical synthesis of cell permeable version of 
KB7 could take some time, there are other ways to introduce the chemical inside cells 
for further preliminary studies. I started some studies with a membrane permealizing 
agent, geraniol. Geraniol can only be used as a tool to introduce effective amounts of 
KB7 into yeast cells, as it is eventually toxic to yeast and human cells (Bard et al., 
1988; Carnesecchi, 2002). In combination with pump mutant strains, I anticipate an 
effective accumulation of KB7 intracellularly to cause sufficient Rtt109 inhibition 
and result in an appreciable decrease in H3K56ac by Western Blot. Upon attaining an 
inhibitory compound that is cell permeable, the in vivo effect of KB7 on 
pathogenicity can be investigated. 
The HTS was performed with recombinant Rtt109 from S. cerevisiae, a non-
pathogenic fungus. The cellular effects presented are performed on C. albicans, a 
pathogenic fungus. Because of the amino acid sequence conservation of Rtt109 
between fungal strains at key residues (Bazan, 2008; Tang et al., 2008), it is likely 
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that KB7 will also inhibit Rtt109 from other fungal species. This assumption should 
also be verified.  
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